<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Antibiotic treatment for the sexual partners of women with bacterial vaginosis - Amaya‐Guio, J - 2016 | Cochrane Library</title> <meta content="Antibiotic treatment for the sexual partners of women with bacterial vaginosis - Amaya‐Guio, J - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011701.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Antibiotic treatment for the sexual partners of women with bacterial vaginosis - Amaya‐Guio, J - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011701.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011701.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Antibiotic treatment for the sexual partners of women with bacterial vaginosis" name="citation_title"/> <meta content="Jairo Amaya‐Guio" name="citation_author"/> <meta content="Faculty of Medicine, Universidad Nacional de Colombia" name="citation_author_institution"/> <meta content="jamayaguio@gmail.com" name="citation_author_email"/> <meta content="David Andres Viveros‐Carreño" name="citation_author"/> <meta content="Faculty of Medicine, Universidad Nacional de Colombia" name="citation_author_institution"/> <meta content="Eloisa Mercedes Sierra‐Barrios" name="citation_author"/> <meta content="Faculty of Medicine, Universidad Nacional de Colombia" name="citation_author_institution"/> <meta content="Mercy Yolima Martinez‐Velasquez" name="citation_author"/> <meta content="Clinica Universitaria Colombia, Sanitas" name="citation_author_institution"/> <meta content="Carlos F Grillo‐Ardila" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD011701.pub2" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/10/01" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011701.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011701.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011701.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Secondary Prevention; *Sexual Partners; Anti‐Bacterial Agents [adverse effects, *therapeutic use]; Clindamycin [therapeutic use]; Indazoles [therapeutic use]; Lincosamides [therapeutic use]; Metronidazole [therapeutic use]; Randomized Controlled Trials as Topic; Recurrence; Time Factors; Tinidazole [therapeutic use]; Vaginosis, Bacterial [*prevention &amp; control]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011701.pub2&amp;doi=10.1002/14651858.CD011701.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011701.pub2&amp;doi=10.1002/14651858.CD011701.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011701.pub2&amp;doi=10.1002/14651858.CD011701.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011701.pub2&amp;doi=10.1002/14651858.CD011701.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011701.pub2&amp;doi=10.1002/14651858.CD011701.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011701.pub2&amp;doi=10.1002/14651858.CD011701.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011701.pub2&amp;doi=10.1002/14651858.CD011701.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011701.pub2&amp;doi=10.1002/14651858.CD011701.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011701.pub2&amp;doi=10.1002/14651858.CD011701.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011701.pub2&amp;doi=10.1002/14651858.CD011701.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011701.pub2&amp;doi=10.1002/14651858.CD011701.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011701.pub2&amp;doi=10.1002/14651858.CD011701.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011701.pub2&amp;doi=10.1002/14651858.CD011701.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011701.pub2&amp;doi=10.1002/14651858.CD011701.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011701.pub2&amp;doi=10.1002/14651858.CD011701.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011701.pub2&amp;doi=10.1002/14651858.CD011701.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011701.pub2&amp;doi=10.1002/14651858.CD011701.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011701.pub2&amp;doi=10.1002/14651858.CD011701.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011701.pub2&amp;doi=10.1002/14651858.CD011701.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011701.pub2&amp;doi=10.1002/14651858.CD011701.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011701.pub2&amp;doi=10.1002/14651858.CD011701.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011701.pub2&amp;doi=10.1002/14651858.CD011701.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011701.pub2&amp;doi=10.1002/14651858.CD011701.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="gpg7sF9V";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011701\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011701\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011701\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011701\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","hr","fr","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011701.pub2",title:"Antibiotic treatment for the sexual partners of women with bacterial vaginosis",firstPublishedDate:"Oct 1, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane STI Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=gpg7sF9V&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011701.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011701.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011701.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011701.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011701.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011701.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011701.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011701.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011701.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011701.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>26940 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011701.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/full#CD011701-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/full#CD011701-sec-0111"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/full#CD011701-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/full#CD011701-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/full#CD011701-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/full#CD011701-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/full#CD011701-sec-0070"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/full#CD011701-sec-0105"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/appendices#CD011701-sec-0116"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/table_n/CD011701StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/table_n/CD011701StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Antibiotic treatment for the sexual partners of women with bacterial vaginosis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/information#CD011701-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Jairo Amaya‐Guio</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/information#CD011701-cr-0003">David Andres Viveros‐Carreño</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/information#CD011701-cr-0004">Eloisa Mercedes Sierra‐Barrios</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/information#CD011701-cr-0005">Mercy Yolima Martinez‐Velasquez</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011701.pub2/information#CD011701-cr-0006">Carlos F Grillo‐Ardila</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/information/en#CD011701-sec-0125">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 01 October 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011701.pub2">https://doi.org/10.1002/14651858.CD011701.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011701-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011701-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011701-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011701-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011701-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011701-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011701-abs-0001" lang="en"> <section id="CD011701-sec-0001"> <h3 class="title" id="CD011701-sec-0001">Background</h3> <p>Bacterial vaginosis (BV) is an infection that has a prevalence between 10% to 50% worlwide. BV results in an imbalance of the normal vaginal flora. Microorganisms associated with BV have been isolated from the normal flora of the male genital tract, and their presence could be related to the recurrence of BV after antibiotic treatment. Therefore, the treatment of sexual partners could decrease the recurrence of infection and possibly the burden of the disease. </p> </section> <section id="CD011701-sec-0002"> <h3 class="title" id="CD011701-sec-0002">Objectives</h3> <p>To assess the effectiveness in women and the safety in men of concurrent antibiotic treatment for the sexual partners of women treated for BV. </p> </section> <section id="CD011701-sec-0003"> <h3 class="title" id="CD011701-sec-0003">Search methods</h3> <p>We searched the Cochrane Sexually Transmitted Infections Group Specialized Register (23 July 2016), CENTRAL (1991 to 23 July 2016), MEDLINE (1946 to 23 July 2016), Embase (1974 to 23 July 2016), LILACS (1982 to 23 July 2016), the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (23 July 2016), ClinicalTrials.gov (23 July 2016) and the Web of Science™ (2001 to 23 July 2016). We also handsearched conference proceedings, contacted trial authors and reviewed the reference lists of retrieved studies. </p> </section> <section id="CD011701-sec-0004"> <h3 class="title" id="CD011701-sec-0004">Selection criteria</h3> <p>Randomized controlled trials (RCTs) that compared the concurrent use of any antibiotic treatment with placebo, no intervention or any other intervention by the sexual partners of women treated for BV. </p> </section> <section id="CD011701-sec-0005"> <h3 class="title" id="CD011701-sec-0005">Data collection and analysis</h3> <p>Three review authors independently assessed trials for inclusion, extracted data and assessed the risk of bias in the included studies. We resolved any disagreements through consensus. We assessed the quality of the evidence using the GRADE approach. </p> </section> <section id="CD011701-sec-0006"> <h3 class="title" id="CD011701-sec-0006">Main results</h3> <p>Seven RCTs (1026 participants) met our inclusion criteria, and pharmaceutical industry funded four of these trials. Five trials (854 patients) compared any antibiotic treatment of sexual partners with placebo. Based on high quality evidence, antibiotic treatment does not increase the rate of clinical or symptomatic improvement in women during the first week (risk ratio (RR) 0.99, 95% confidence interval (CI) 0.96 to 1.03; 712 participants, four studies; RR 1.06, 95% CI 1.00 to 1.12; 577 patients, three studies, respectively), between the first and fourth week (RR 1.02, 95% CI 0.94 to 1.11; 590 participants, three studies; RR 0.93, 95% CI 0.84 to 1.03; 444 participants, two studies; respectively) or after the fourth week (RR 0.98, 95% CI 0.90 to 1.07; 572 participants, four studies; RR 1.03, 95% CI 0.90 to 1.17; 296 participants, two studies; respectively). Antibiotic treatment does not led to a lower recurrence during the first and fourth week (RR 1.28, 95% CI 0.68 to 2.43; 218 participants, one study; low quality evidence) or after the fourth week of treatment (RR 1.00, 95% CI 0.67 to 1.52; 372 participants, three studies; low quality evidence) in women, but increases the frequency of adverse events (most frequently gastrointestinal symptoms) reported by sexual partners (RR 2.55, 95% CI 1.55 to 4.18; 477 participants, three studies; low quality evidence).<br/> <br/> Two trials (172 participants) compared any antibiotic treatment for sexual partners with no intervention. When we compared it with no intervention, the effects of antibiotic treatment on recurrence rate after the fourth week (RR 1.71, 95% CI 0.65 to 4.55; 51 participants, one study), clinical improvement between the first and fourth week (RR 0.93, 95% CI 0.70 to 1.25; 152 participants, two studies) and symptomatic improvement after the fourth week (RR 0.66, 95% CI 0.39 to 1.11; 70 participants, one study) were imprecise and there were no differences between groups. We downgraded the quality of the evidence to low or very low. </p> </section> <section id="CD011701-sec-0007"> <h3 class="title" id="CD011701-sec-0007">Authors' conclusions</h3> <p>High quality evidence shows that antibiotic treatment for sexual partners of women with BV, compared with placebo, does not increase the rate of clinical or symptomatic improvement during the first, between the first and fourth or after the fourth week into the women. Low quality evidence suggests that antibiotic treatment does not led to a lower recurrence rate during the first and fourth or after the fourth week of treatment into the women, but increases the frequency of adverse events reported by sexual partners. Finally, compared with no intervention, antibiotic treatment does not decrease the recurrence rate after the fourth week and does not increase the frequency of clinical or symptomatic improvement between the first and fourth or after the fourth week into the women, respectively. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011701-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011701-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011701-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011701-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011701-abs-0007">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD011701-abs-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD011701-abs-0005">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011701-abs-0012">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011701-abs-0004" lang="en"> <h3>Antibiotic treatment for the sexual partners of women with bacterial vaginosis</h3> <p><b>Review question</b> </p> <p>We assessed the effectiveness in women and the safety in men of concurrent antibiotic treatment for the sexual partners of women treated for bacterial vaginosis (BV). </p> <p><b>Background</b> </p> <p>Bacterial vaginosis (BV) is an infection that has a prevalence between 10% to 50% worlwide. BV results in an imbalance of the normal vaginal flora. Microorganisms associated with BV have been isolated from the normal flora of the male genital tract, and their presence could be related to the recurrence of infection after antibiotic treatment. Therefore, the treatment of sexual partners could offer the advantages of decreasing the recurrence of infection and possibly reducing the burden of the disease. </p> <p><b>Trial characteristics</b> </p> <p>Cochrane researchers searched the available literature up to the 23 July 2016 and included seven trials with 1026 participants. The trials included sexually‐active non‐pregnant women between 17 and 56 years of age, either single or married, with symptomatic BV. Four studies only included women involved into a monogamous heterosexual relationship and there was no information about this for the remaining trials. Six trials used 5‐nitroimidazoles to treat the sexual partner, four trials used metronidazole and two trials used tinidazole; only one study used a lincosamide for treatment. Five trials compared antibiotic versus placebo (854 participants) and two trials compared antibiotic treatment with no intervention (172 participants). Pharmaceutical companies funded four of the included trials. </p> <p><b>Key results</b> </p> <p>Compared with placebo, antibiotic treatment for the sexual partners of women treated for BV had no effects on clinical or symptomatic improvement in women, regardless of the time period over which the trials assessed these outcomes (during the first, between the first and fourth, or after the fourth week). Furthermore, antibiotic treatment of the sexual partner may have no effect on the recurrence of BV up to 12 weeks after treatment, but may increase the frequency of minor adverse events reported by sexual partners. Compared with no intervention, treatment of sexual partners of women with BV may have no effect on decreasing the recurrence rate or over the frequency of clinical or symptomatic improvement between the first and fourth or after the fourth week, respectively. </p> <p><b>Quality of evidence</b> </p> <p>The quality of evidence was high for the outcomes of clinical and symptomatic improvement. The quality of evidence was very low for recurrence due to some limitations regarding risk of bias and imprecision. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011701-sec-0111" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011701-sec-0111">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011701-sec-0153">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011701-sec-0111"></div> <h3 class="title" id="CD011701-sec-0112">Implications for practice</h3> <section id="CD011701-sec-0112"> <p>Given the high quality evidence for most outcomes we assessed in this Cochrane Review, there is no benefit of antibiotic treatment compared with placebo for sexual partners of women with BV. Also, there is no increase in the rate of clinical or symptomatic improvement during the first, between the first and fourth or after the fourth week of treatment into the women. There is still some uncertainty due to the low quality of evidence, which suggests that antibiotic treatment does not led to a lower recurrence rate during the first and fourth or after the fourth week of treatment into the women, but increases the frequency of adverse events reported by sexual partners. </p> </section> <h3 class="title" id="CD011701-sec-0113">Implications for research</h3> <section id="CD011701-sec-0113"> <p>Due to the high quality of evidence for most included outcomes in this Cochrane Review, future studies that evaluate the same outcomes will probably not change our conclusions. However, there is a need for high‐quality RCTs that assess recurrence rate adequately, treatment of female partners, treatment for pregnant patients, use of other antibiotic treatments occasionally prescribed in clinical practice such as aminopenicillins and macrolides, and cost effectiveness of interventions. Therefore, study authors should focus their investigations on these problems in the future. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011701-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011701-sec-0029"></div> <div class="table" id="CD011701-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Any antibiotic treatment versus placebo</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Any antibiotic treatment versus placebo for the sexual partners of woman with bacterial vaginosis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> sexual partners of women with bacterial vaginosis<br/> <b>Setting:</b> outpatient clinic<br/> <b>Intervention:</b> any antibiotic treatment<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with any antibiotic treatment</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Recurrence</b> </p> <p>follow‐up 4 to 12 weeks</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.00<br/> (0.67 to 1.52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>372<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> very low<sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>196 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>196 per 1000<br/> (131 to 297) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Clinical improvement</b> </p> <p>follow‐up 1 to 4 weeks</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.02<br/> (0.94 to 1.11) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>590<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>778 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>794 per 1000<br/> (731 to 864) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Clinical improvement</b> </p> <p>follow‐up 4 to 12 weeks</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.98<br/> (0.90 to 1.07) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>572<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>778 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>762 per 1000<br/> (700 to 832) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Symptomatic improvement</b> </p> <p>during the first week</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.06<br/> (1.00 to 1.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>577<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>863 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>914 per 1000<br/> (863 to 966) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Symptomatic improvement</b> </p> <p>follow‐up 1 to 4 weeks</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.93<br/> (0.84 to 1.03) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>444<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>801 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>745 per 1000<br/> (673 to 825) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Symptomatic improvement</b> </p> <p>follow‐up 4 to 12 weeks</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.03<br/> (0.90 to 1.17) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>296<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>743 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>766 per 1000<br/> (669 to 870) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Minor adverse events in sexual partner</b> <br/> follow‐up: 1 to 12 weeks </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.55<br/> (1.55 to 4.18) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>477<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>80 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>204 per 1000<br/> (124 to 335) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>Abbreviations: CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>OR:</b> odds ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by 1 level for significant imprecision as the 95% CI was below 0.75 and over 1.25.<br/> <sup>2</sup>Downgraded by 2 levels for imprecision as the 95% CI crosses through 0.75 and 1.25 and OIS is not achieved.<br/> <sup>3</sup>Downgraded by 2 levels for imprecision because the Optimal information size (OIS) was not achieved. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011701-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Any antibiotic treatment versus no intervention</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Any antibiotic treatment versus no intervention</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> sexual partners of women with bacterial vaginosis<br/> <b>Setting:</b> outpatient clinic<br/> <b>Intervention:</b> any antibiotic treatment<br/> <b>Comparison:</b> no intervention </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no intervention</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with any antibiotic treatment</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Recurrence</b> </p> <p>follow‐up 4 to 12 weeks</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.71<br/> (0.65 to 4.55) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>51<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> very low<sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>194 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>333 per 1000<br/> (126 to 885) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Clinical improvement</b> </p> <p>follow‐up 1 to 4 weeks</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.93<br/> (0.70 to 1.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>152<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> very low<sup>1,2,3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>851 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>792 per 1000<br/> (596 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Symptomatic improvement</b> </p> <p>follow‐up 4 to 12 weeks</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.66<br/> (0.39 to 1.11) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>70<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> very low<sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>630 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>416 per 1000<br/> (246 to 700) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>Abbreviations: CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>OR:</b> odds ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by 2 levels due to imprecision as OIS was not achieved and the 95% CI crosses through 0.75 and 1.25.<br/> <sup>2</sup>Downgraded by 2 levels as there were some limitations on blinding and incomplete outcome data domains.<br/> <sup>3</sup>Downgraded by 1 level for substantial heterogeneity (I² statistic is greater than 40%). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011701-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Any antibiotic treatment versus placebo</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Any antibiotic treatment versus placebo</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> sexual partners of women with bacterial vaginosis<br/> <b>Setting:</b> outpatient clinics<br/> <b>Intervention:</b> any antibiotic treatment<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with any antibiotic treatment</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Recurrence</b> <br/> follow‐up 1 to 4 weeks </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.28<br/> (0.68 to 2.43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>218<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>132 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>169 per 1000<br/> (90 to 321) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Clinical improvement</b> during the first week </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.99<br/> (0.96 to 1.03) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>712<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>951 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>942 per 1000<br/> (913 to 980) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>Abbreviations: CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>OR:</b> odds ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by 2 levels for imprecision as the 95% CI crosses through 0.75 and 1.25 and OIS is not achieved. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011701-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011701-sec-0030">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011701-sec-0133">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD011701-sec-0030"></div> <section id="CD011701-sec-0031"> <h3 class="title" id="CD011701-sec-0031">Description of the condition</h3> <p>Secretions from the vagina (known as vaginal discharge) are a normal occurrence and result from cervical secretion and other components derived from micro‐organisms that colonize the vaginal flora, mostly lactobacilli (<a href="./references#CD011701-bbs2-0054" title="MylonasI , BergauerF . Diagnosis of vaginal discharge by wet mount microscopy: a simple and underrated method. Obstetrical &amp; Gynecological Survey2011;66(6):359‐68. ">Mylonas 2011</a>). Lactobacilli play a predominant role in vaginal homeostasis through the production of lactic acid, hydrogen peroxide and bacteriocins, which are compounds that control the overgrowth of pathogenic micro‐organisms (<a href="./references#CD011701-bbs2-0061" title="TaylorBD , DarvilleT , HaggertyCL . Does bacterial vaginosis cause pelvic inflammatory disease?. Sexually Transmitted Diseases2013;40(2):117‐22. ">Taylor 2013</a>). An increase in the amount of vaginal discharge is usually associated with the presence of a genital tract infection (<a href="./references#CD011701-bbs2-0054" title="MylonasI , BergauerF . Diagnosis of vaginal discharge by wet mount microscopy: a simple and underrated method. Obstetrical &amp; Gynecological Survey2011;66(6):359‐68. ">Mylonas 2011</a>). Women with an abnormal vaginal discharge most commonly have bacterial vaginosis (BV) (39.6%) or, less frequently, vulvovaginal candidiasis (11%) or trichomoniasis (0.8%); however, the exact etiology of the vaginal discharge can change according to the population (<a href="./references#CD011701-bbs2-0068" title="Ángel‐MüllerE , RodríguezA , Núñez‐ForeroLM , MoyanoLF , GonzálezP , OsorioE , et al. The prevalence of and factors associated with C. trachomatis, N. gonorrheae, T. vaginalis, C. albicans infection, syphilis, HIV and bacterial vaginosis in females suffering lower genital tract infection symptoms in three healthcare attention sites in Bogotá, Colombia, 2010. Revista Colombiana de Obstetricia y Ginecología2012;63(1):25‐35. ">Ángel‐Müller 2012</a>). BV is thought to arise as a result of an imbalance in the normal vaginal flora when lactobacilli decrease in concentration and are replaced by anaerobic and facultative aerobic bacteria (<a href="./references#CD011701-bbs2-0061" title="TaylorBD , DarvilleT , HaggertyCL . Does bacterial vaginosis cause pelvic inflammatory disease?. Sexually Transmitted Diseases2013;40(2):117‐22. ">Taylor 2013</a>), such as <i>Gardnerella vaginalis</i> (40%) or, less frequently, by <i>Mycoplasma hominis</i> , <i>Clostridia</i> (<a href="./references#CD011701-bbs2-0052" title="MirmonsefP , KrassL , LandayA , SpearGT . The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract. Current HIV Research2012;10(3):202‐10. ">Mirmonsef 2012</a>), <i>Peptostreptococcus</i> or <i>Mobiluncus</i> (<a href="./references#CD011701-bbs2-0054" title="MylonasI , BergauerF . Diagnosis of vaginal discharge by wet mount microscopy: a simple and underrated method. Obstetrical &amp; Gynecological Survey2011;66(6):359‐68. ">Mylonas 2011</a>). Although the precise cause of this dysbacteriosis is not completely understood, some factors, such as high sexual activity, a new sexual partner and risky sexual behavior (<a href="./references#CD011701-bbs2-0024" title="BradshawCS , MortonAN , GarlandSM , MorrisMB , MossLM , FairleyCK . Higher‐risk behavioral practices associated with bacterial vaginosis compared with vaginal candidiasis. Obstetrics and Gynecology2005;106(1):105–14. [PUBMED: 15994624] ">Bradshaw 2005</a>; <a href="./references#CD011701-bbs2-0052" title="MirmonsefP , KrassL , LandayA , SpearGT . The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract. Current HIV Research2012;10(3):202‐10. ">Mirmonsef 2012</a>; <a href="./references#CD011701-bbs2-0054" title="MylonasI , BergauerF . Diagnosis of vaginal discharge by wet mount microscopy: a simple and underrated method. Obstetrical &amp; Gynecological Survey2011;66(6):359‐68. ">Mylonas 2011</a>), could contribute to this condition (<a href="./references#CD011701-bbs2-0054" title="MylonasI , BergauerF . Diagnosis of vaginal discharge by wet mount microscopy: a simple and underrated method. Obstetrical &amp; Gynecological Survey2011;66(6):359‐68. ">Mylonas 2011</a>). </p> <p>BV is found worldwide with a prevalence between 10% and 50%, and is usually higher among sex workers, the HIV‐positive population, black and Hispanic women (<a href="./references#CD011701-bbs2-0044" title="KenyonC , ColebundersR , CrucittiT . The global epidemiology of bacterial vaginosis: a systematic review. American Journal of Obstetrics and Gynecology2013;209(6):505‐23. ">Kenyon 2013</a>), and among women with a new or a high number of sexual partners (<a href="./references#CD011701-bbs2-0049" title="MarrazzoJM . Interpreting the epidemiology and natural history of bacterial vaginosis: are we still confused?. Anaerobe2011;17(4):186‐90. ">Marrazzo 2011</a>). Having three or more male sexual partners in the past 12 months has been identified as a risk factor for BV (<a href="./references#CD011701-bbs2-0049" title="MarrazzoJM . Interpreting the epidemiology and natural history of bacterial vaginosis: are we still confused?. Anaerobe2011;17(4):186‐90. ">Marrazzo 2011</a>). Also, having a female sexual partner has been reported to increase the risk of BV by 60% (<a href="./references#CD011701-bbs2-0060" title="SmartS , SingalA , MindelA . Social and sexual risk factors for bacterial vaginosis. Sexually Transmitted Infections2004;80(1):58‐62. ">Smart 2004</a>). The burden of BV is related not only to the prevalence of the condition, but also to a reduction in quality of life, as well as to anxiety and self‐conscious feelings relating to the fear of exclusion due to the foul smell associated with the infection (<a href="./references#CD011701-bbs2-0022" title="BilardiJE , WalkerS , Temple‐SmithM , McNairR , Mooney‐SomersJ , BellhouseC , et al. The burden of bacterial vaginosis: women’s experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis. PLoS One2013;8(9):e74378. ">Bilardi 2013</a>). The bacteria associated with BV may be carried by male genitalia, but men are usually asymptomatic (<a href="./references#CD011701-bbs2-0055" title="NelsonDE , DongQ , Van derPolB , TohE , FanB , KatzBP , et al. Bacterial communities of the coronal sulcus and distal urethra of adolescent males. PLoS One2012;7(5):e36298. [PUBMED: 22606251] ">Nelson 2012</a>). The direct cost of BV care has been evaluated in pregnant women, and is particularly related to the complications of pregnancy that derive from it: in a study evaluating a population from the USA, the Netherlands and the UK it was estimated that the overall cost of BV was around one thousand million USD a year (<a href="./references#CD011701-bbs2-0057" title="Oleen‐BurkeyMA , HillierSL . Pregnancy complications associated with bacterial vaginosis and their estimated costs. Infectious Diseases in Obstetrics and Gynecology1995;3(4):149–57. ">Oleen‐Burkey 1995</a>). BV has also been associated with a risk of acquiring a sexually transmitted infection (STI), such as pelvic inflammatory disease (<a href="./references#CD011701-bbs2-0052" title="MirmonsefP , KrassL , LandayA , SpearGT . The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract. Current HIV Research2012;10(3):202‐10. ">Mirmonsef 2012</a>; <a href="./references#CD011701-bbs2-0061" title="TaylorBD , DarvilleT , HaggertyCL . Does bacterial vaginosis cause pelvic inflammatory disease?. Sexually Transmitted Diseases2013;40(2):117‐22. ">Taylor 2013</a>), and infections caused by <i>Neisseria gonorrhoeae</i> , <i>Chlamydiia trachomatis</i> and HIV (<a href="./references#CD011701-bbs2-0052" title="MirmonsefP , KrassL , LandayA , SpearGT . The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract. Current HIV Research2012;10(3):202‐10. ">Mirmonsef 2012</a>), and with a higher risk of developing cervical cancer (<a href="./references#CD011701-bbs2-0037" title="GilletE , MeysJF , VerstraelenH , VerhelstR , DeSutterP , TemmermanM , et al. Association between bacterial vaginosis and cervical intraepithelial neoplasia: systematic review and meta‐analysis. PLoS One2012;7(10):e45201. ">Gillet 2012</a>), and even subfertility (<a href="./references#CD011701-bbs2-0061" title="TaylorBD , DarvilleT , HaggertyCL . Does bacterial vaginosis cause pelvic inflammatory disease?. Sexually Transmitted Diseases2013;40(2):117‐22. ">Taylor 2013</a>). In addition, BV may increase the risk of adverse perinatal outcomes, such as low birth weight, preterm delivery and very low birth weight (<a href="./references#CD011701-bbs2-0059" title="SangkomkamhangUS , LumbiganonP , PrasertcharoensookW , LaopaiboonM . Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery. Cochrane Database of Systematic Reviews2015, Issue 2. [DOI: 10.1002/14651858.CD006178.pub3] ">Sangkomkamhang 2008</a>), and may result in approximately 80,000 excess preterm births every year in the USA (<a href="./references#CD011701-bbs2-0038" title="GoldenbergRL , CulhaneJF , JohnsonDC . Maternal infection and adverse fetal and neonatal outcomes. Clinics in Perinatology2005;32(3):523‐59. ">Goldenberg 2005</a>). </p> <p>The Amsel criteria and Gram staining can be used to diagnose BV, and Gram staining is considered the gold standard for this purpose (<a href="./references#CD011701-bbs2-0064" title="WorkowskiKA , BolanGA , Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep2015;64(RR‐03):1‐137. ">Workowski 2015</a>). The Nugent scoring system is applied to Gram stains of vaginal smears to visually estimate the numbers of lactobacilli and BV‐associated organisms; a Nugent score of zero to three is considered healthy, four to six is intermediate and a score of seven to ten implies the presence of BV (<a href="./references#CD011701-bbs2-0027" title="BrotmanRM . Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective. Journal of Clinical Investigation2011;121(12):4610‐7. ">Brotman 2011</a>). This method has a number of disadvantages: a trained professional is required for the interpretation of results and the Gram stain is unable to detect some micro‐organisms, such as Ureaplasma and Mycoplasma (<a href="./references#CD011701-bbs2-0061" title="TaylorBD , DarvilleT , HaggertyCL . Does bacterial vaginosis cause pelvic inflammatory disease?. Sexually Transmitted Diseases2013;40(2):117‐22. ">Taylor 2013</a>). When Gram staining is not possible, the Amsel criteria provide a good clinical tool for the diagnosis of BV, which requires the presence of at least three of the following four criteria (<a href="./references#CD011701-bbs2-0061" title="TaylorBD , DarvilleT , HaggertyCL . Does bacterial vaginosis cause pelvic inflammatory disease?. Sexually Transmitted Diseases2013;40(2):117‐22. ">Taylor 2013</a>). </p> <p> <ul id="CD011701-list-0001"> <li> <p>Homogeneous, thin, white vaginal discharge.</p> </li> <li> <p>Presence of clue cells on microscopic examination.</p> </li> <li> <p>A pH greater than 4.5.</p> </li> <li> <p>A positive ‘whiff test’ (a fishy odour after 10% potassium hydroxide is added).</p> </li> </ul> </p> <p>In vitro cultures for <i>G. vaginalis</i> are of limited utility because although cultures in almost all women with a symptomatic infection are positive, 50% of the cultures from healthy asymptomatic women are also positive (<a href="./references#CD011701-bbs2-0054" title="MylonasI , BergauerF . Diagnosis of vaginal discharge by wet mount microscopy: a simple and underrated method. Obstetrical &amp; Gynecological Survey2011;66(6):359‐68. ">Mylonas 2011</a>). Finally, in some circumstances a diagnosis can be reached through combining the medical history with the clinical characterization of the discharge during a gynaecological examination (<a href="./references#CD011701-bbs2-0051" title="Ministerio de Saludy Protección Social ‐ Colciencias . Clinical Practice Guideline for the syndromic approach to the diagnosis and treatment of patients with sexually transmitted infections and other infections of the genital tract. [Guía de práctica clínica para el manejo sindrómico de los pacientes con infecciones de transmisión sexual y otras infecciones del tracto genital]. http://gpc.minsalud.gov.co/gpc_sites/repositorio/conv_500/GPC_its/gpc_its.aspx April 2013. Accessed 23/07/2015. ">Ministerio de Salud y Protección Social 2013</a>). This approach, the syndromic approach, is based on the assumption that genital tract infections share some common symptoms and signs thus making it possible to assign them a specific etiology without the need for a laboratory test (<a href="./references#CD011701-bbs2-0051" title="Ministerio de Saludy Protección Social ‐ Colciencias . Clinical Practice Guideline for the syndromic approach to the diagnosis and treatment of patients with sexually transmitted infections and other infections of the genital tract. [Guía de práctica clínica para el manejo sindrómico de los pacientes con infecciones de transmisión sexual y otras infecciones del tracto genital]. http://gpc.minsalud.gov.co/gpc_sites/repositorio/conv_500/GPC_its/gpc_its.aspx April 2013. Accessed 23/07/2015. ">Ministerio de Salud y Protección Social 2013</a>). </p> <p>BV is not currently considered a STI but it is well‐recognized that both have many aspects in common (<a href="./references#CD011701-bbs2-0053" title="MorrisMC , RogersPA , KinghornGR . Is bacterial vaginosis a sexually transmitted infection?. Sexually Transmitted Infections2001;77(1):63‐8. [PUBMED: 11158694] ">Morris 2001</a>). Several studies have reported an association between BV and the coexistence of STIs, risky sexual behaviours, young age at first sexual intercourse, sharing sexual toys, and a new or multiple male or female partners (<a href="./references#CD011701-bbs2-0029" title="ChavezN , MolinaH , SánchezJ , GelayeB , SánchezSE . Douches and other risks of bacterial vaginosis [Duchas vaginales y otros riesgos de vaginosis bacteriana]. Revista Peruana de Medicina Experimental y Salud Pública2009;26(3):299–306. [PUBMED: 21132048] ">Chavez 2009</a>; <a href="./references#CD011701-bbs2-0033" title="FethersKA , FairleyCK , HockingJS , GurrinLC , BradshawCS . Sexual risk factors and bacterial vaginosis: a systematic review and meta‐analysis. Clinical Infectious Diseases2008;47(11):1426–35. [PUBMED: 18947329] ">Fethers 2008</a>; <a href="./references#CD011701-bbs2-0034" title="FethersKA , FairleyCK , MortonA , HockingJS , HopkinsC , KennedyLJ , et al. Early sexual experiences and risk factors for bacterial vaginosis. Journal of Infectious Diseases2009;200(11):1662‐70. [PUBMED: 19863439] ">Fethers 2009</a>; <a href="./references#CD011701-bbs2-0048" title="MarrazzoJ , CoffeyP , BinghamA . Sexual practices, risk perception and knowledge of sexually transmitted disease risk among lesbian and bisexual women. Perspectives on Sexual and Reproductive Health2005;37(1):6‐12. [PUBMED: 15888397] ">Marrazzo 2005</a>; <a href="./references#CD011701-bbs2-0053" title="MorrisMC , RogersPA , KinghornGR . Is bacterial vaginosis a sexually transmitted infection?. Sexually Transmitted Infections2001;77(1):63‐8. [PUBMED: 11158694] ">Morris 2001</a>). Furthermore, BV is unusual in women without a history of sexual contact (<a href="./references#CD011701-bbs2-0034" title="FethersKA , FairleyCK , MortonA , HockingJS , HopkinsC , KennedyLJ , et al. Early sexual experiences and risk factors for bacterial vaginosis. Journal of Infectious Diseases2009;200(11):1662‐70. [PUBMED: 19863439] ">Fethers 2009</a>), and its prevalence is less frequent in women who report that they regularly use condoms or have a stable sexual partner (<a href="./references#CD011701-bbs2-0029" title="ChavezN , MolinaH , SánchezJ , GelayeB , SánchezSE . Douches and other risks of bacterial vaginosis [Duchas vaginales y otros riesgos de vaginosis bacteriana]. Revista Peruana de Medicina Experimental y Salud Pública2009;26(3):299–306. [PUBMED: 21132048] ">Chavez 2009</a>; <a href="./references#CD011701-bbs2-0033" title="FethersKA , FairleyCK , HockingJS , GurrinLC , BradshawCS . Sexual risk factors and bacterial vaginosis: a systematic review and meta‐analysis. Clinical Infectious Diseases2008;47(11):1426–35. [PUBMED: 18947329] ">Fethers 2008</a>); these findings are consistent with a strong association between BV and sexual activity (<a href="./references#CD011701-bbs2-0034" title="FethersKA , FairleyCK , MortonA , HockingJS , HopkinsC , KennedyLJ , et al. Early sexual experiences and risk factors for bacterial vaginosis. Journal of Infectious Diseases2009;200(11):1662‐70. [PUBMED: 19863439] ">Fethers 2009</a>). </p> <p>Additionally, some studies have proposed that the bacteria associated with BV may be carried by the male genitalia (<a href="./references#CD011701-bbs2-0055" title="NelsonDE , DongQ , Van derPolB , TohE , FanB , KatzBP , et al. Bacterial communities of the coronal sulcus and distal urethra of adolescent males. PLoS One2012;7(5):e36298. [PUBMED: 22606251] ">Nelson 2012</a>), based on the microbiological isolation of the micro‐organisms associated with this infection in the flora of the penis and urethra in male partners of infected females (<a href="./references#CD011701-bbs2-0047" title="MandarR . Microbiota of male genital tract: impact on the health of man and his partner. Pharmacological Research2013;69(1):32–41. [PUBMED: 23142212] ">Mandar 2013</a>; <a href="./references#CD011701-bbs2-0055" title="NelsonDE , DongQ , Van derPolB , TohE , FanB , KatzBP , et al. Bacterial communities of the coronal sulcus and distal urethra of adolescent males. PLoS One2012;7(5):e36298. [PUBMED: 22606251] ">Nelson 2012</a>). This is particularly notable in uncircumcized males in whom the presence of a major surface of contact could have a major role as a reservoir, and favour the occurrence of an infection after sexual intercourse (<a href="./references#CD011701-bbs2-0009" title="BukusiE , ThomasKK , NgutiR , CohenCR , WeissN , CoombsRW , et al. Topical penile microbicide use by men to prevent recurrent bacterial vaginosis in sex partners: a randomized clinical trial. Sexually Transmitted Diseases2011;38(6):483‐9. ">Bukusi 2011</a>; <a href="./references#CD011701-bbs2-0017" title="MehtaSD . Systematic review of randomised trials of treatment of male sexual partners for improved bacteria vaginosis outcomes in women. Sexually Transmitted Diseases2012;39(10):822‐30. ">Mehta 2012</a>). Bacteria associated with BV have been isolated from the normal flora of the male coronal sulcus and urethra, and could be related to infection in female partners and to the recurrence of infection after treatment (seen in about 20% of individuals and defined as three or more proven episodes of BV in 12 months) (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>; <a href="./references#CD011701-bbs2-0030" title="CookRL , Redondo‐LopezV , SchmittC , MeriwetherC , SobelJD . Clinical, microbiological and biochemical factors in recurrent bacterial vaginosis. Journal of Clinical Microbiology1992;30(4):870‐7. ">Cook 1992</a>). Another mechanism for infection could be the mechanical transfer of perineal enteric bacteria from the flora of the male genitalia through unprotected and protected intercourse (<a href="./references#CD011701-bbs2-0047" title="MandarR . Microbiota of male genital tract: impact on the health of man and his partner. Pharmacological Research2013;69(1):32–41. [PUBMED: 23142212] ">Mandar 2013</a>). </p> </section> <section id="CD011701-sec-0032"> <h3 class="title" id="CD011701-sec-0032">Description of the intervention</h3> <p>As BV is considered to arise from an imbalance in the normal vaginal flora (<a href="./references#CD011701-bbs2-0061" title="TaylorBD , DarvilleT , HaggertyCL . Does bacterial vaginosis cause pelvic inflammatory disease?. Sexually Transmitted Diseases2013;40(2):117‐22. ">Taylor 2013</a>), treatment includes the administration of antibiotics, such as nitroimidazoles, lincosamides, macrolides (e.g. erythromycin) and, in some circumstances, penicillins (<a href="./references#CD011701-bbs2-0056" title="OduyeboOO , AnorluRI , OgunsolaFT . The effects of antimicrobial therapy on bacterial vaginosis in non‐pregnant women. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD006055.pub2] ">Oduyebo 2009</a>; <a href="./references#CD011701-bbs2-0064" title="WorkowskiKA , BolanGA , Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep2015;64(RR‐03):1‐137. ">Workowski 2015</a>), the objective being to eradicate the abnormal vaginal bacterial flora (<a href="./references#CD011701-bbs2-0054" title="MylonasI , BergauerF . Diagnosis of vaginal discharge by wet mount microscopy: a simple and underrated method. Obstetrical &amp; Gynecological Survey2011;66(6):359‐68. ">Mylonas 2011</a>). 5‐Nitroimidazole derivatives are available for oral and intravaginal administration (<a href="./references#CD011701-bbs2-0064" title="WorkowskiKA , BolanGA , Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep2015;64(RR‐03):1‐137. ">Workowski 2015</a>). These medications are absorbed completely after oral intake and the volume of distribution of these agents approximates to that of total body water because they are associated with a low level of protein binding (<a href="./references#CD011701-bbs2-0045" title="LampKC , FreemanCD , KlutmanNE , LacyMK . Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials. Clinical Pharmacokinetics1999;36(5):353‐73. ">Lamp 1999</a>). 5‐Nitroimidazole derivatives penetrate well into body tissues and fluids, with the exception of the placenta, and are eliminated in the urine after being metabolized in the liver (<a href="./references#CD011701-bbs2-0028" title="BruntonLL , ChabnerBA , KnollmanBC , editors. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th Edition. New York (NY): McGraw‐Hill Companies Inc., 2011. ">Brunton 2011</a>; <a href="./references#CD011701-bbs2-0062" title="TrevorAJ , KatzungBG , Kruidering‐HallM , MastersSB . Katzung &amp; Trevor's Pharmacology Examination and Board Review. 10th Edition. New York (NY): McGraw‐Hill Companies Inc., 2012. ">Trevor 2012</a>). The side effects of 5‐nitroimidazoles are usually mild and the most common are headache, nausea, dry mouth and a metallic taste (<a href="./references#CD011701-bbs2-0028" title="BruntonLL , ChabnerBA , KnollmanBC , editors. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th Edition. New York (NY): McGraw‐Hill Companies Inc., 2011. ">Brunton 2011</a>; <a href="./references#CD011701-bbs2-0062" title="TrevorAJ , KatzungBG , Kruidering‐HallM , MastersSB . Katzung &amp; Trevor's Pharmacology Examination and Board Review. 10th Edition. New York (NY): McGraw‐Hill Companies Inc., 2012. ">Trevor 2012</a>). The regimens recommended for the treatment of BV include metronidazole 500 mg orally twice a day for seven days or metronidazole gel 0.75% one full applicator (5 g) intravaginally once a day for five days; tinidazole 2 g orally once daily for one or two days or 1 g orally once daily for five days; or secnidazole 1 g or 2 g orally in single doses (<a href="./references#CD011701-bbs2-0056" title="OduyeboOO , AnorluRI , OgunsolaFT . The effects of antimicrobial therapy on bacterial vaginosis in non‐pregnant women. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD006055.pub2] ">Oduyebo 2009</a>; <a href="./references#CD011701-bbs2-0064" title="WorkowskiKA , BolanGA , Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep2015;64(RR‐03):1‐137. ">Workowski 2015</a>). </p> <p>Clindamycin, the most representative of the lincosamides, is almost completely absorbed following oral administration (<a href="./references#CD011701-bbs2-0023" title="BouazzaN , PestreV , JullienV , CurisE , UrienS , SalmonD , et al. Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis. British Journal of Clinical Pharmacology2012;74(6):971‐7. ">Bouazza 2012</a>), with a half‐life of about three hours, and is widely distributed into fluids and tissues (<a href="./references#CD011701-bbs2-0023" title="BouazzaN , PestreV , JullienV , CurisE , UrienS , SalmonD , et al. Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis. British Journal of Clinical Pharmacology2012;74(6):971‐7. ">Bouazza 2012</a>; <a href="./references#CD011701-bbs2-0036" title="GattiG , FlahertyJ , BubpJ , WhiteJ , BorinM , GambertoglioJ . Comparative study of bioavailabilities and pharmacokinetics of clindamycin in healthy volunteers and patients with AIDS. Antimicrobial Agents and Chemotherapy1993;37(5):1137‐43. ">Gatti 1993</a>). More than 80% of this agent is bound to plasma proteins, primarily α1‐acid glycoprotein (<a href="./references#CD011701-bbs2-0035" title="FlahertyJFJr , GattiG , WhiteJ , BubpJ , BorinM , GambertoglioJG . Protein binding of clindamycin in sera of patients with AIDS. Antimicrobial Agents and Chemotherapy1996;40(5):1134‐8. ">Flaherty 1996</a>); it is metabolized in the liver by cytochrome P450 3A4 and is excreted in the urine and bile (<a href="./references#CD011701-bbs2-0062" title="TrevorAJ , KatzungBG , Kruidering‐HallM , MastersSB . Katzung &amp; Trevor's Pharmacology Examination and Board Review. 10th Edition. New York (NY): McGraw‐Hill Companies Inc., 2012. ">Trevor 2012</a>; <a href="./references#CD011701-bbs2-0065" title="WynaldaMA , HutzlerJM , KoetsMD , PodollT , WienkersLC . In vitro metabolism of clindamycin in human liver and intestinal microsomes. Drug Metabolism and Disposition2003;31(7):878‐87. ">Wynalda 2003</a>, <a href="./references#CD011701-bbs2-0066" title="YasudaK , RanadeA , VenkataramananR , StromS , ChupkaJ , EkinsS , et al. A comprehensive in vitro and in silico analysis of antibiotics that activate pregnane X receptor and induce CYP3A4 in liver and intestine. Drug Metabolism and Disposition2008;36(8):1689‐97. ">Yasuda 2008</a>). The most common side effects related to the administration of clindamycin include diarrhoea and, in a small number of individuals, pseudomembranous colitis (<a href="./references#CD011701-bbs2-0040" title="GurwithMJ , RabinHR , LoveK . Diarrhea associated with clindamycin and ampicillin therapy: preliminary results of a cooperative study. Journal of Infectious Diseases1977;135 Suppl:S104‐10. ">Gurwith 1977</a>). Rash can occur in about 10% of individuals; other reactions, such as Stevens‐Johnson syndrome, the reversible elevation of transaminases, granulocytopenia, thrombocytopenia and anaphylactic reactions, are less frequent (<a href="./references#CD011701-bbs2-0028" title="BruntonLL , ChabnerBA , KnollmanBC , editors. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th Edition. New York (NY): McGraw‐Hill Companies Inc., 2011. ">Brunton 2011</a>). Regimens suggested for the treatment of BV include clindamycin cream 2% one full applicator (5 mg) intravaginally at bedtime for seven days; clindamycin 300 mg orally twice daily for seven days; or clindamycin ovules 100 mg intravaginally once at bedtime for three days (<a href="./references#CD011701-bbs2-0064" title="WorkowskiKA , BolanGA , Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep2015;64(RR‐03):1‐137. ">Workowski 2015</a>). </p> <p>The serum half‐life of erythromycin is approximately two hours (<a href="./references#CD011701-bbs2-0043" title="JosefssonK , BerganT , MagniL . Dose‐related pharmacokinetics after oral administration of a new formulation of erythromycin base. British Journal of Clinical Pharmacology1982;13(5):685‐91. ">Josefsson 1982</a>; <a href="./references#CD011701-bbs2-0067" title="ZuckermanJM , QamarF , BonoBR . Review of macrolides (azithromycin, clarithromycin), ketolids (telithromycin) and glycylcyclines (tigecycline). Medical Clinics of North America2011;95(4):761‐91. ">Zuckerman 2011</a>). The drug is metabolized in the liver by cytochrome P450 3A4 and 2% to 5% is eliminated in an active form in the urine (<a href="./references#CD011701-bbs2-0062" title="TrevorAJ , KatzungBG , Kruidering‐HallM , MastersSB . Katzung &amp; Trevor's Pharmacology Examination and Board Review. 10th Edition. New York (NY): McGraw‐Hill Companies Inc., 2012. ">Trevor 2012</a>; <a href="./references#CD011701-bbs2-0067" title="ZuckermanJM , QamarF , BonoBR . Review of macrolides (azithromycin, clarithromycin), ketolids (telithromycin) and glycylcyclines (tigecycline). Medical Clinics of North America2011;95(4):761‐91. ">Zuckerman 2011</a>). Cholestatic hepatitis is the most notable side effect of macrolides and hepatotoxicity has also been observed (<a href="./references#CD011701-bbs2-0031" title="DerbyLE , JickH , HenryDA , DeanAD . Erythromycin‐associated cholestatic hepatitis. Medical Journal of Australia1993;158(9):600‐2. ">Derby 1993</a>). Large doses have been associated with abdominal cramps, nausea, vomiting and diarrhoea (<a href="./references#CD011701-bbs2-0067" title="ZuckermanJM , QamarF , BonoBR . Review of macrolides (azithromycin, clarithromycin), ketolids (telithromycin) and glycylcyclines (tigecycline). Medical Clinics of North America2011;95(4):761‐91. ">Zuckerman 2011</a>). Among the recognized allergic reactions are fever, eosinophilia and skin eruptions, which may occur alone or in combination; all disappear shortly after therapy is suspended (<a href="./references#CD011701-bbs2-0028" title="BruntonLL , ChabnerBA , KnollmanBC , editors. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th Edition. New York (NY): McGraw‐Hill Companies Inc., 2011. ">Brunton 2011</a>). Erythromycin for the treatment of BV is used at a dose of 333 mg oral three times daily for 14 days in combination with metronidazole (<a href="./references#CD011701-bbs2-0026" title="BrocklehurstP , GordonA , HeatleyE , MilanSJ . Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database of Systematic Reviews2013, Issue 1. [DOI: 10.1002/14651858.CD000262.pub4] ">Brocklehurst 2013</a>). </p> <p>Some studies have used the aminopenicillin amoxicillin for the treatment of BV (<a href="./references#CD011701-bbs2-0021" title="AmitA , RawatDS , RawatMSM . 5‐Nitroimidazole derivatives: a scope of modification for medicinal chemists. Research Journal of Chemical Science2013;3(7):104‐13. ">Amit 2013</a>; <a href="./references#CD011701-bbs2-0026" title="BrocklehurstP , GordonA , HeatleyE , MilanSJ . Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database of Systematic Reviews2013, Issue 1. [DOI: 10.1002/14651858.CD000262.pub4] ">Brocklehurst 2013</a>). This agent is a semi‐synthetic penicillin with a half‐life of almost 80 minutes, which binds to proteins in the plasma and is excreted renally (<a href="./references#CD011701-bbs2-0026" title="BrocklehurstP , GordonA , HeatleyE , MilanSJ . Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database of Systematic Reviews2013, Issue 1. [DOI: 10.1002/14651858.CD000262.pub4] ">Brocklehurst 2013</a>). The most important side effects associated with amoxicillin are nausea, vomiting, rash and antibiotic‐associated colitis. The use of ampicillin is now generally avoided due to the emergence of ampicillin‐resistant bacteria in individuals with BV (<a href="./references#CD011701-bbs2-0021" title="AmitA , RawatDS , RawatMSM . 5‐Nitroimidazole derivatives: a scope of modification for medicinal chemists. Research Journal of Chemical Science2013;3(7):104‐13. ">Amit 2013</a>). </p> </section> <section id="CD011701-sec-0033"> <h3 class="title" id="CD011701-sec-0033">How the intervention might work</h3> <p>To date, the evidence regarding whether to treat or not the sexual partner of a woman with BV is inconclusive (<a href="./references#CD011701-bbs2-0050" title="MehtaSD . Response to Madhivanan et al. Sexually Transmitted Diseases2013;40(6):518‐9. ">Mehta 2013</a>; <a href="./references#CD011701-bbs2-0018" title="PotterJ . Should sexual partners of women with bacterial vaginosis receive treatment?. British Journal of General Practice1999;49(448):913‐8. ">Potter 1999</a>). As frequently‐used antibiotics for treating BV are widely distributed into the fluids and tissues of the human body (<a href="./references#CD011701-bbs2-0023" title="BouazzaN , PestreV , JullienV , CurisE , UrienS , SalmonD , et al. Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis. British Journal of Clinical Pharmacology2012;74(6):971‐7. ">Bouazza 2012</a>; <a href="./references#CD011701-bbs2-0028" title="BruntonLL , ChabnerBA , KnollmanBC , editors. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th Edition. New York (NY): McGraw‐Hill Companies Inc., 2011. ">Brunton 2011</a>; <a href="./references#CD011701-bbs2-0036" title="GattiG , FlahertyJ , BubpJ , WhiteJ , BorinM , GambertoglioJ . Comparative study of bioavailabilities and pharmacokinetics of clindamycin in healthy volunteers and patients with AIDS. Antimicrobial Agents and Chemotherapy1993;37(5):1137‐43. ">Gatti 1993</a>; <a href="./references#CD011701-bbs2-0062" title="TrevorAJ , KatzungBG , Kruidering‐HallM , MastersSB . Katzung &amp; Trevor's Pharmacology Examination and Board Review. 10th Edition. New York (NY): McGraw‐Hill Companies Inc., 2012. ">Trevor 2012</a>), the treatment of sexual partners could eliminate the abnormal flora present in the male genital area that may promote relapse in, or reinfection of, women with BV (<a href="./references#CD011701-bbs2-0025" title="BradshawCS , MortonAN , HockingJ , GarlandSM , MorrisMB , MossLM , et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. Journal of Infectious Diseases2006;193(11):1478‐86. [PUBMED: 16652274] ">Bradshaw 2006</a>). </p> <p>The 5‐nitroimidazole derivatives are agents with antiprotozoal and antibacterial properties (<a href="./references#CD011701-bbs2-0021" title="AmitA , RawatDS , RawatMSM . 5‐Nitroimidazole derivatives: a scope of modification for medicinal chemists. Research Journal of Chemical Science2013;3(7):104‐13. ">Amit 2013</a>). When a 5‐nitroimidazole enters the cellular environment, it is reduced by the pyruvate ferredoxin oxidoreductase system present in bacterial mitochondria, which modifies its chemical structure (<a href="./references#CD011701-bbs2-0021" title="AmitA , RawatDS , RawatMSM . 5‐Nitroimidazole derivatives: a scope of modification for medicinal chemists. Research Journal of Chemical Science2013;3(7):104‐13. ">Amit 2013</a>). Pyruvate ferredoxin oxidoreductase generates adenosine triphosphate (ATP) via the oxidative decarboxylation of pyruvate; in the presence of a structurally modified 5‐nitroimidazole, the electrons that would be transferred to hydrogen ions during the generation of ATP are captured by the nitro group (<a href="./references#CD011701-bbs2-0021" title="AmitA , RawatDS , RawatMSM . 5‐Nitroimidazole derivatives: a scope of modification for medicinal chemists. Research Journal of Chemical Science2013;3(7):104‐13. ">Amit 2013</a>). This disruption of ATP production promotes the formation of intermediate compounds and free radicals that are highly toxic to the bacteria (<a href="./references#CD011701-bbs2-0028" title="BruntonLL , ChabnerBA , KnollmanBC , editors. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th Edition. New York (NY): McGraw‐Hill Companies Inc., 2011. ">Brunton 2011</a>). The lincosamides bind to the 50S subunit of bacterial ribosomes and consequentially suppress bacterial protein synthesis (<a href="./references#CD011701-bbs2-0028" title="BruntonLL , ChabnerBA , KnollmanBC , editors. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th Edition. New York (NY): McGraw‐Hill Companies Inc., 2011. ">Brunton 2011</a>; <a href="./references#CD011701-bbs2-0062" title="TrevorAJ , KatzungBG , Kruidering‐HallM , MastersSB . Katzung &amp; Trevor's Pharmacology Examination and Board Review. 10th Edition. New York (NY): McGraw‐Hill Companies Inc., 2012. ">Trevor 2012</a>). The macrolides (e.g. erythromycin) are bacteriostatic agents that inhibit protein synthesis by binding reversibly to the 50S ribosomal subunits of sensitive micro‐organisms (<a href="./references#CD011701-bbs2-0028" title="BruntonLL , ChabnerBA , KnollmanBC , editors. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th Edition. New York (NY): McGraw‐Hill Companies Inc., 2011. ">Brunton 2011</a>; <a href="./references#CD011701-bbs2-0062" title="TrevorAJ , KatzungBG , Kruidering‐HallM , MastersSB . Katzung &amp; Trevor's Pharmacology Examination and Board Review. 10th Edition. New York (NY): McGraw‐Hill Companies Inc., 2012. ">Trevor 2012</a>). </p> <p>The administration of any effective and safe intervention to the sexual partner of a woman with BV could offer the advantages of decreasing the recurrence of infection, thus breaking the chain of infection and possibly decreasing the prevalence of STIs, reducing the burden associated with the condition and impacting positively on the sexual and reproductive health of the woman (<a href="./references#CD011701-bbs2-0050" title="MehtaSD . Response to Madhivanan et al. Sexually Transmitted Diseases2013;40(6):518‐9. ">Mehta 2013</a>). </p> </section> <section id="CD011701-sec-0034"> <h3 class="title" id="CD011701-sec-0034">Why it is important to do this review</h3> <p>This systematic review is of paramount importance as some studies suggest that BV exhibits a behaviour similar to that of an STI (<a href="./references#CD011701-bbs2-0018" title="PotterJ . Should sexual partners of women with bacterial vaginosis receive treatment?. British Journal of General Practice1999;49(448):913‐8. ">Potter 1999</a>). However, there is still some uncertainty regarding whether recurrence of BV in women could be due to a failure to eradicate the causative organism(s) or a consequence of reinfection by the sexual partner (<a href="./references#CD011701-bbs2-0025" title="BradshawCS , MortonAN , HockingJ , GarlandSM , MorrisMB , MossLM , et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. Journal of Infectious Diseases2006;193(11):1478‐86. [PUBMED: 16652274] ">Bradshaw 2006</a>). Currently, the treatment of sexual partners of women with BV is not recommended (<a href="./references#CD011701-bbs2-0064" title="WorkowskiKA , BolanGA , Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep2015;64(RR‐03):1‐137. ">Workowski 2015</a>), but this is based on the critical appraisal of individual clinical trials (none of which provide conclusive evidence regarding the efficacy and safety of male sex partner treatment for women with BV (<a href="./references#CD011701-bbs2-0050" title="MehtaSD . Response to Madhivanan et al. Sexually Transmitted Diseases2013;40(6):518‐9. ">Mehta 2013</a>)) rather than a synthesis of the available clinical evidence (<a href="./references#CD011701-bbs2-0017" title="MehtaSD . Systematic review of randomised trials of treatment of male sexual partners for improved bacteria vaginosis outcomes in women. Sexually Transmitted Diseases2012;39(10):822‐30. ">Mehta 2012</a>; <a href="./references#CD011701-bbs2-0018" title="PotterJ . Should sexual partners of women with bacterial vaginosis receive treatment?. British Journal of General Practice1999;49(448):913‐8. ">Potter 1999</a>). If the treatment of sexual partners were found to reduce the rate of recurrence of BV then this could reduce costs. However, it would need to be weighed against the possible risk of antibiotic resistance that could arise from the additional multiple treatments such a policy would involve. There is therefore a need for high‐quality systematic reviews to improve the clinical management of BV (<a href="./references#CD011701-bbs2-0046" title="MadhivananP , BarretoGA , RevawalaA , AndersonC , McKinneyS , Pierre‐VictorD . Where are we with partner treatment in bacterial vaginosis? A critical appraisal of the latest systematic review. Sexually Transmitted Diseases2013;40(6):518. ">Madhivanan 2013</a>). This systematic review will facilitate the synthesis of the current evidence, and recognize its strengths and weakness, address the uncertainty of the current knowledge and make it possible to assess the effectiveness and safety of this intervention. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011701-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011701-sec-0035">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011701-sec-0138">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011701-sec-0035"></div> <p>To assess the effectiveness in women and the safety in men of concurrent antibiotic treatment for the sexual partners of women treated for BV. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011701-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011701-sec-0036">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011701-sec-0139">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011701-sec-0036"></div> <section id="CD011701-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011701-sec-0038"> <h4 class="title">Types of studies</h4> <p>Randomized controlled clinical trials, published and unpublished, that compared the concurrent use of any antibiotic treatment (any concentration, frequency, duration and route) with placebo, no intervention or any other intervention (any concentration, frequency, duration and route) by the sexual partners of women treated for bacterial vaginosis (BV). We excluded quasi‐randomized trials because this approach produces effect estimates that indicate more extreme benefits compared with those generated by randomized controlled clinical trials (<a href="./references#CD011701-bbs2-0042" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We also excluded cross‐over trials and cluster‐randomized trials because of the nature of the condition (<a href="./references#CD011701-bbs2-0042" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> </section> <section id="CD011701-sec-0039"> <h4 class="title">Types of participants</h4> <p>The sexual partners (either male or female) of women treated for non‐recurrent BV.</p> </section> <section id="CD011701-sec-0040"> <h4 class="title">Types of interventions</h4> <p>Any antibiotic treatment (at any concentration, frequency, duration and route) versus one of the following. </p> <p> <ul id="CD011701-list-0002"> <li> <p>Placebo.</p> </li> <li> <p>No intervention.</p> </li> <li> <p>Any other intervention different to antibiotic treatment (any concentration, frequency, duration and route). </p> </li> </ul> </p> </section> <section id="CD011701-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD011701-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD011701-list-0003"> <li> <p>Recurrence of BV in women treated for BV (proportion of participants who were previously healthy following treatment for BV that developed a new episode of BV, according to Amsel's criteria or any other clinical criteria). </p> </li> <li> <p>Clinical improvement (according to Amsel's criteria or any other clinical criteria) in women treated for BV. </p> </li> <li> <p>Symptomatic improvement defined as the (self‐reported) improvement or disappearance of symptoms in women treated for BV. </p> </li> <li> <p>Serious adverse events of the intervention (hypersensitivity, pseudomembranous colitis or Stevens‐Johnson syndrome) in sexual partners of women treated for BV. </p> </li> </ul> </p> </section> <section id="CD011701-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD011701-list-0004"> <li> <p>Minor adverse events of the intervention during therapy (metallic taste, nausea, vomiting, diarrhoea or headache) in sexual partners of women treated for BV. </p> </li> <li> <p>Cost‐effectiveness of the intervention.</p> </li> </ul> </p> <p>The primary outcomes (recurrence, clinical and symptomatic improvement) were assessed during the first week, between the first and fourth week and after the fourth week. We assessed adverse events of the intervention during therapy. </p> </section> </section> </section> <section id="CD011701-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <p>We identified as many relevant randomized controlled trials (RCTs) of "antibiotic treatment" for the "sexual partner of the woman being treated for bacterial vaginosis" as possible, irrespective of language of publication, publication date and publication status (published, unpublished, in press or in progress). We used both the electronic searching of bibliographic databases and handsearching, as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011701-bbs2-0042" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> <section id="CD011701-sec-0045"> <h4 class="title">Electronic searches</h4> <p>We contacted the Information specialist of the Cochrane Sexually Transmitted Infections Group in order to implement a comprehensive search strategy to identify as many relevant RCTs as possible in the electronic databases. We used a combination of controlled vocabulary (MeSH, Emtree terms, Health Sciences Descriptors ‐DeCS for its acronym in Spanish‐, including exploded terms) and free‐text terms (considering spelling variants, synonyms, acronyms and truncation) for "sexual partner of the woman being treated for bacterial vaginosis" and "antibiotic treatment", with field labels, proximity operators and boolean operators. We have listed our search strategies in the 'Appendices' section (<a href="./appendices#CD011701-sec-0117">Appendix 1</a>; <a href="./appendices#CD011701-sec-0118">Appendix 2</a>; <a href="./appendices#CD011701-sec-0119">Appendix 3</a>; <a href="./appendices#CD011701-sec-0120">Appendix 4</a>; <a href="./appendices#CD011701-sec-0121">Appendix 5</a>; <a href="./appendices#CD011701-sec-0122">Appendix 6</a>; <a href="./appendices#CD011701-sec-0123">Appendix 7</a>). </p> <p>We searched the following electronic databases.</p> <p> <ul id="CD011701-list-0005"> <li> <p>Cochrane Sexually Transmitted Infections Group Specialized Register (searched 23 July 2016). </p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL), Ovid platform (searched from Cochrane Library Issue 1, 1991 to 23 July 2016). </p> </li> <li> <p>MEDLINE, Ovid platform (searched from 1946 to 23 July 2016).</p> </li> <li> <p>MEDLINE In‐Process &amp; Other Non‐Indexed Citations, Ovid platform (searched from 1966 to 23 July 2016). </p> </li> <li> <p>MEDLINE Daily Update, Ovid platform (searched from 1966 to 23 July 2016).</p> </li> <li> <p>Embase (searched from 1974 to 23 July 2016).</p> </li> <li> <p>LILACS (Latin American and Caribbean Health Sciences Literature, IAHx interface; searched from 1982 to 23 July 2016). </p> </li> </ul> </p> <p>For MEDLINE, we used the Cochrane highly sensitive search strategy for identifying RCTs: sensitivity and precision maximizing version (2008 revision), Ovid format (<a href="./references#CD011701-bbs2-0042" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We combined the LILACS search strategy with the RCT filter of the IAHx interface. </p> </section> <section id="CD011701-sec-0046"> <h4 class="title">Searching other resources</h4> <p>We searched the following resources for additional trials.</p> <p> <ul id="CD011701-list-0006"> <li> <p>Trial registers:</p> <ul id="CD011701-list-0007"> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) portal (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>): searched 23 Jul 2016; </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov/</a>): searched 23 July 2016. </p> </li> </ul> </li> <li> <p>Web of Science™: searched from 2001 to 23 July 2016.</p> </li> </ul> </p> <p>We contacted the trial authors of all RCTs we identified by other methods and handsearched the conference proceeding abstracts of the following events. </p> <p> <ul id="CD011701-list-0008"> <li> <p>International Society for Sexually Transmitted Diseases Research (ISSTDR) (<a href="http://www.isstdr.org/" target="_blank">www.isstdr.org/</a>) scientific meetings: 2007, 2009 and 2011. </p> </li> <li> <p>British Association for Sexual Health and HIV (BASHH) (<a href="http://www.bashh.org/" target="_blank">www.bashh.org/</a>) scientific meetings: 2004, 2006, 2007 and 2009. </p> </li> <li> <p>The International Congress on Infectious Diseases (ICID) (<a href="http://www.isid.org/" target="_blank">www.isid.org/</a>): 2010 and 2012. </p> </li> <li> <p>International Union against Sexually Transmitted Infections (IUSTI) (<a href="http://www.iusti.org/" target="_blank">www.iusti.org/</a>) conferences and meetings: 2011 and 2012. </p> </li> <li> <p>International Society for Infectious Diseases (ISID) (<a href="http://www.isid.org/" target="_blank">www.isid.org/</a>): 2011. </p> </li> <li> <p>International Meeting on Emerging Diseases and Surveillance (IMED) (<a href="http://www.isid.org/" target="_blank">www.isid.org/</a>): 2007, 2009 and 2011. </p> </li> <li> <p>Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) (<a href="http://www.icaac.org/" target="_blank">www.icaac.org/</a>): 2011 and 2012. </p> </li> <li> <p>International Federation of Gynecology and Obstetrics (FIGO) (<a href="http://www.figo.org/" target="_blank">www.figo.org/</a>) World Congress: 2012. </p> </li> </ul> </p> <p>We also handsearched previous systematic reviews and other relevant publications on the same topic and the reference lists of all RCTs identified by other methods. </p> </section> </section> <section id="CD011701-sec-0047"> <h3 class="title" id="CD011701-sec-0047">Data collection and analysis</h3> <section id="CD011701-sec-0048"> <h4 class="title">Selection of studies</h4> <p>Three review authors (JA‐G, DAV‐C and EMS‐B) independently assessed the titles and abstracts of the records we retrieved from the search strategy for inclusion. Three review authors independently performed the final selection of trials for inclusion and we resolved any disagreements through discussion. We listed all excluded studies and the reasons for exclusion in a "<a href="./references#CD011701-sec-0131" title="">Characteristics of excluded studies</a>" table and we constructed a PRISMA diagram to illustrated the study selection process (<a href="#CD011701-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD011701-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD011701-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD011701-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>We designed a data extraction form, which we pilot tested with one of the included studies. Three review authors (CFG‐A, DAV‐C and EMS‐B) independently extracted the data from the included studies using the finalized data extraction form. We resolved any disagreements regarding the extracted data through discussion until we reached a consensus. </p> <p>We extracted data on the following items.</p> <p> <ul id="CD011701-list-0009"> <li> <p>Location of the trial and setting.</p> </li> <li> <p>Trial design.</p> </li> <li> <p>Power calculation performed.</p> </li> <li> <p>Inclusion and exclusion criteria.</p> </li> <li> <p>Baseline information of the participants in order to have comparable intervention groups at entry (age, marital status, contraceptive habits, sexual intercourse during treatment, history of sexually transmitted infections (STIs), sexual behavioral history). </p> </li> <li> <p>Total number of intervention groups.</p> </li> <li> <p>Types of interventions: antibiotic type (any concentration, frequency, duration and route). </p> </li> <li> <p>Types of comparison: placebo, no intervention or any other intervention (any concentration, frequency, duration and route). </p> </li> <li> <p>Number of participants enrolled, randomized and excluded after randomization and analysed.</p> </li> <li> <p>Number of participants lost to follow‐up in the groups.</p> </li> <li> <p>Outcomes stated in the methods versus outcomes reported in the results.</p> </li> <li> <p>How the trial authors defined the secondary outcomes.</p> </li> <li> <p>Differences between groups for outcome assessment.</p> </li> <li> <p>Time of follow‐up in participants for specific outcomes.</p> </li> <li> <p>How the trial authors validated adverse event reports.</p> </li> <li> <p>Funding sources reported.</p> </li> <li> <p>Ethical issues: use of signed informed consent and ethics approval.</p> </li> </ul> </p> <p>For eligible studies, two review authors (CFG‐A and MYM‐V) entered the data into Review Manager (RevMan) (<a href="./references#CD011701-bbs2-0058" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>), and checked them for accuracy. When information regarding any of the above was unclear, we contacted authors of the original reports to ask for further details. For a single RCT report, we extracted data directly into a data collection form; in cases of multiple reports, we extracted data from each report separately and then combined information across data collection forms. </p> </section> <section id="CD011701-sec-0050"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (CFG‐A and JA‐G) independently assessed the risk of bias for each included study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011701-bbs2-0042" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We resolved any disagreement by consensus or we consulted a third review author (MYM‐V). The review authors that assessed the risk of bias in the included studies were theme and methodology experts. In order to collect missing information, we planned to contact the study investigators using open‐ended questions. </p> <section id="CD011701-sec-0051"> <h5 class="title">1. Random sequence generation (checking for possible selection bias)</h5> <p>We described, for each included study, the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. We assessed the method as follows. </p> <p> <ul id="CD011701-list-0010"> <li> <p>Low risk of bias (any truly random process, e.g. random number table; computer random number generator). </p> </li> <li> <p>High risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number). </p> </li> <li> <p>Unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD011701-sec-0052"> <h5 class="title">2. Allocation concealment (checking for possible selection bias)</h5> <p>For each included study we reported the method used to conceal allocation to interventions prior to assignment and we assessed whether intervention allocation could have been foreseen in advance of, or during, recruitment or changed after assignment. We assessed the methods as follows. </p> <p> <ul id="CD011701-list-0011"> <li> <p>Low risk of bias (e.g. telephone or central randomization; consecutively numbered sealed opaque envelopes). </p> </li> <li> <p>High risk of bias (open random allocation; unsealed or non opaque envelopes, alternation; date of birth). </p> </li> <li> <p>Unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD011701-sec-0053"> <h5 class="title">3a. Blinding of participants and personnel (checking for possible performance bias)</h5> <p>We described, for each included study, the methods used, if any, to blind study participants and personnel from the knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding would have been unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes. We assessed the methods as follows. </p> <p> <ul id="CD011701-list-0012"> <li> <p>Low, high or unclear risk of bias for participants.</p> </li> <li> <p>Low, high or unclear risk of bias for personnel.</p> </li> </ul> </p> </section> <section id="CD011701-sec-0054"> <h5 class="title">3b. Blinding of outcome assessment (checking for possible detection bias)</h5> <p>We described the methods used, if any, to blind outcome assessors from the knowledge of which intervention a participant received for each included study. We assessed blinding separately for different outcomes or classes of outcomes. We also assessed methods used to blind outcome assessment as at either low, high or unclear risk of bias. </p> </section> <section id="CD011701-sec-0055"> <h5 class="title">4. Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>We described, for each included study, and for each outcome or class of outcomes, the completeness of the data including attrition and exclusions from the analysis. We stated whether the trial authors reported attrition and exclusions and the number of participants included in the analysis at each stage (compared with the total number of randomized participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where an included study reported sufficient information, we re‐included missing data in the analyses we undertook. We assessed methods as follows. </p> <p> <ul id="CD011701-list-0013"> <li> <p>Low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups). </p> </li> <li> <p>High risk of bias (e.g. numbers or reasons for missing data imbalance across groups; ‘as treated’ analysis done with substantial departure of intervention received from that assigned at randomization). </p> </li> <li> <p>Unclear risk of bias.</p> </li> </ul> </p> <p>We used a cut‐off point of 20% to determine whether a study was at low or high risk of bias according to the level of missing data. </p> </section> <section id="CD011701-sec-0056"> <h5 class="title">5. Selective reporting (checking for reporting bias)</h5> <p>For each included study, we described how we investigated the possibility of selective outcome reporting bias and what we found. We assessed the methods as follows. </p> <p> <ul id="CD011701-list-0014"> <li> <p>Low risk of bias (where it was clear that the study authors reported all of the study's prespecified outcomes and all expected outcomes of interest). </p> </li> <li> <p>High risk of bias (where the study authors did not report all of the study’s prespecified outcomes; the study authors did not prespecify one or more reported primary outcomes; the study authors incompletely reported the outcomes of interest and so we could not used them; the study failed to include the results of a key outcome that we would expected them to have reported). </p> </li> <li> <p>Unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD011701-sec-0057"> <h5 class="title">6. Other bias (checking for bias due to problems not covered by (1) to (5) above)</h5> <p>We described, for each included study, any important concerns we had about other possible sources of bias. We assessed whether each included study was free of other problems that could put it at risk of bias. We assessed methods as follows. </p> <p> <ul id="CD011701-list-0015"> <li> <p>Low risk of other bias.</p> </li> <li> <p>High risk of other bias.</p> </li> <li> <p>Unclear risk of other bias.</p> </li> </ul> </p> </section> <section id="CD011701-sec-0058"> <h5 class="title">Overall risk of bias</h5> <p>We made explicit judgments about whether studies were at high risk of bias, according to the criteria given in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011701-bbs2-0042" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we considered it was likely to impact on the findings. We explored the impact of the level of bias by undertaking sensitivity analyses (see the '<a href="#CD011701-sec-0069">Sensitivity analysis</a>' section). </p> </section> </section> <section id="CD011701-sec-0059"> <h4 class="title">Measures of treatment effect</h4> <section id="CD011701-sec-0060"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we reported the results as risk ratios (RRs) with 95% confidence intervals (CIs). The RR is used as a relative effect measure, which works well with a low or high rate of events, and is easy to interpret and use in clinical practice. </p> </section> <section id="CD011701-sec-0061"> <h5 class="title">Continuous data</h5> <p>For continuous data, we used the mean difference if outcomes were measured in the same way between trials. We used the standardized mean difference to combine trials that measured the same outcome but used different methods. </p> </section> </section> <section id="CD011701-sec-0062"> <h4 class="title">Unit of analysis issues</h4> <p>The units of analysis were individuals instead of couples. We assessed the effect of the intervention independently in the partner and the woman that constitute the couple. The sexual partner of the woman was randomized to the intervention or comparison group, but all the women included in the study received treatment for BV. </p> <p>Where we identified a clinical trial that randomized participants to several intervention groups, we determined which intervention groups were relevant. To avoid confusion for the reader, we included all the intervention groups of the study in the '<a href="./references#CD011701-sec-0130" title="">Characteristics of included studies</a>' table (in the notes cell), and provided a detailed description only of the intervention groups that were relevant to this review, and we only used these groups in our analyses. Finally, in order to overcome a unit‐of‐analysis error for a study that could contribute multiple correlated comparisons, we combined all relevant experimental intervention groups of the studies into a single group and also combined all relevant control intervention groups into a single control group, in order to create a single pairwise comparison (<a href="./references#CD011701-bbs2-0042" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> </section> <section id="CD011701-sec-0063"> <h4 class="title">Dealing with missing data</h4> <p>We identified the levels of attrition in the included trials and we performed analyses for all outcomes, as far as possible, on an intention‐to‐treat basis, i.e. we attempted to include all participants randomized to each group in the analyses, and we analysed all participants in the group to which they were allocated, regardless of whether or not they received the allocated intervention. The denominator for each outcome in each trial was the number randomized minus any participants whose outcomes were known to be missing. We explored the impact of including trials with high levels of missing data in the overall assessment of treatment effects by using sensitivity analysis (see the '<a href="#CD011701-sec-0069">Sensitivity analysis</a>' section). </p> </section> <section id="CD011701-sec-0064"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity in each meta‐analysis using the Tau², I² statistic and Chi² test values (<a href="./references#CD011701-bbs2-0042" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We regarded heterogeneity as substantial if the I² statistic value was greater than 40% and if either the Tau² value was greater than zero or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. </p> </section> <section id="CD011701-sec-0065"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to explored publication bias through assessment of funnel plot asymmetry and formal tests. For continuous outcomes, we planned to use the test proposed by <a href="./references#CD011701-bbs2-0032" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ1997;315(7109):629‐34. ">Egger 1997</a>, and for dichotomous outcomes we planned to use the test proposed by <a href="./references#CD011701-bbs2-0041" title="HarbordRM , EggerM , SterneJA . A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints. Statistics in Medicine2006;25(20):3443‐57. ">Harbord 2006</a>. However, we included fewer than 10 trials in the meta‐analysis so we did not perform these analyses. </p> </section> <section id="CD011701-sec-0066"> <h4 class="title">Data synthesis</h4> <p>We performed statistical analyses using RevMan (<a href="./references#CD011701-bbs2-0058" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We used a fixed‐effect model to combine data when it was reasonable to assume that studies estimated the same underlying treatment effect i.e. where trials examined the same intervention, and we judged the trials’ populations and methods to be sufficiently similar. We used a random‐effects model if there were clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials or, if we detected substantial statistical heterogeneity, to produce an overall summary if an average treatment effect across trials was considered clinically meaningful. We treated the random‐effects summary as the average range of possible treatment effects and we discussed the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful, we did not combine trials. </p> <section id="CD011701-sec-0067"> <h5 class="title">'Summary of findings’ table</h5> <p>We used the GRADE approach in order to produce a 'Summary of findings' table for the outcomes recurrence after treatment, clinical and symptomatic improvement and minor or serious adverse events (<a href="./references#CD011701-bbs2-0042" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We downgraded the quality of evidence depending on the presence of the following factors. </p> <p> <ul id="CD011701-list-0016"> <li> <p>Study limitations.</p> </li> <li> <p>Inconsistency of results.</p> </li> <li> <p>Indirectness of evidence.</p> </li> <li> <p>Imprecision.</p> </li> <li> <p>Publication bias.</p> </li> </ul> </p> </section> </section> <section id="CD011701-sec-0068"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned explore the following potential sources of heterogeneity using subgroup analyses. </p> <p> <ul id="CD011701-list-0017"> <li> <p>Comparison of different antibiotic types (5‐nitroimidazole, lincosamides or any other antibiotic type). </p> </li> <li> <p>Comparison of different durations of antibiotic therapy (single versus multiple doses).</p> </li> <li> <p>Comparison of women with monogamous relationships and women with multiple sexual partners.</p> </li> </ul> </p> <p>We restricted subgroup analyses to the primary outcomes:</p> <p> <ul id="CD011701-list-0018"> <li> <p>Recurrence after treatment into the women.</p> </li> <li> <p>Clinical improvement.</p> </li> <li> <p>Symptomatic improvement.</p> </li> </ul> </p> <p>Given that the safety and effectiveness of health interventions can differ within and between populations, we proposed a subgroup analysis according to low‐ versus high‐income countries. For fixed‐effect inverse variance meta‐analyses we assessed differences between subgroups by interaction tests. For fixed‐effect meta‐analyses using methods other than inverse variance, we assessed differences between subgroups by inspection of the CIs of the subgroups: non‐overlapping CIs indicate a statistically significant difference in treatment effect between the subgroups. </p> </section> <section id="CD011701-sec-0069"> <h4 class="title">Sensitivity analysis</h4> <p>We performed sensitivity analyses based on aspects of the review that may have affected the results; for example, the impact of including trials at high or unclear risk of bias for incomplete outcome data domain. We also carried out a sensitivity analysis to explore the inclusion of the effects of fixed‐effect or random‐effects analysis for outcomes with statistical heterogeneity. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011701-sec-0070" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011701-sec-0070"></div> <section id="CD011701-sec-0071"> <h3 class="title">Description of studies</h3> <section id="CD011701-sec-0072"> <h4 class="title">Results of the search</h4> <p>We searched the available literature up to 23 July 2016 and retrieved a total of 110 references, of which we screened 80 after we removed duplicates. Of these, we initially screened the full‐text articles of 20 references. Seven published trials met our inclusion criteria (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>; <a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a>; <a href="./references#CD011701-bbs2-0003" title="MengelMB , BergAO , WeaverCH , HermanDJ , HermanSJ , HughesVL , et al. The effectiveness of single‐dose metronidazole therapy for patients and their partners with bacterial vaginosis. Journal of Family Practice1989;28(2):163‐71. ">Mengel 1989</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0005" title="SwedbergJ , SteinerJF , DeissF , SteinerS , DriggersDA . Comparison of single‐dose vs one‐week course of metronidazole for symptomatic bacterial vaginosis. JAMA1985;254(8):1046‐9. ">Swedberg 1985</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>). We excluded 12 studies (see the '<a href="./references#CD011701-sec-0131" title="">Characteristics of excluded studies</a>' table) and one trial is currently recruiting participants (see the '<a href="./references#CD011701-sec-0132" title="">Characteristics of ongoing studies</a>' table). We have presented a PRISMA diagram in <a href="#CD011701-fig-0001">Figure 1</a> to illustrate the study selection process. </p> </section> <section id="CD011701-sec-0073"> <h4 class="title">Included studies</h4> <p>The seven included trials had a total of 1026 participants and sample sizes ranged from 82 to 250 participants. These trials were from Denmark (<a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>), Finland (<a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a>), Italy (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>), Thailand (<a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>), the USA (<a href="./references#CD011701-bbs2-0003" title="MengelMB , BergAO , WeaverCH , HermanDJ , HermanSJ , HughesVL , et al. The effectiveness of single‐dose metronidazole therapy for patients and their partners with bacterial vaginosis. Journal of Family Practice1989;28(2):163‐71. ">Mengel 1989</a>; <a href="./references#CD011701-bbs2-0005" title="SwedbergJ , SteinerJF , DeissF , SteinerS , DriggersDA . Comparison of single‐dose vs one‐week course of metronidazole for symptomatic bacterial vaginosis. JAMA1985;254(8):1046‐9. ">Swedberg 1985</a>), and one trial involved the participation of institutions located in four Nordic countries namely Denmark, Finland, Norway and Sweden (<a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>). Three trials were multicentric (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>; <a href="./references#CD011701-bbs2-0003" title="MengelMB , BergAO , WeaverCH , HermanDJ , HermanSJ , HughesVL , et al. The effectiveness of single‐dose metronidazole therapy for patients and their partners with bacterial vaginosis. Journal of Family Practice1989;28(2):163‐71. ">Mengel 1989</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>), only one trial implemented a valid method for sample size calculation (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>), and all trials included outpatients and were published in English. </p> <section id="CD011701-sec-0074"> <h5 class="title">Population</h5> <p>The included studies recruited sexually‐active non‐pregnant women between 17 and 56 years of age, either single or married, with symptomatic BV. Four studies only included women who were involved into a monogamous heterosexual relationship (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>; <a href="./references#CD011701-bbs2-0003" title="MengelMB , BergAO , WeaverCH , HermanDJ , HermanSJ , HughesVL , et al. The effectiveness of single‐dose metronidazole therapy for patients and their partners with bacterial vaginosis. Journal of Family Practice1989;28(2):163‐71. ">Mengel 1989</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>), and there was no information about this for the remaining trials (<a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a>; <a href="./references#CD011701-bbs2-0005" title="SwedbergJ , SteinerJF , DeissF , SteinerS , DriggersDA . Comparison of single‐dose vs one‐week course of metronidazole for symptomatic bacterial vaginosis. JAMA1985;254(8):1046‐9. ">Swedberg 1985</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>). All included trials used the Amsel's criteria to diagnose the presence of the condition and required the discovery of at least three of these four criteria, in the absence of clinical evidence of mucopurulent <br/>cervicitis, trichomoniasis, genital herpes, papilloma virus or candidiasis. The included studies excluded participants with a recent history of systemic or topical <br/>antibiotic treatment for other condition different to bacterial vaginosis (BV). </p> <p>There were no restrictions regarding the concurrent use of contraceptive methods during the treatment period, except for <a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>, which excluded barrier method users. Four studies specified the contraceptive method at entry (<a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>), and the most frequently used was the birth control pill, followed by intrauterine device, tubal resection and the condom. Two trials allowed sexual activity during the study (<a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>), while <a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a> invited the participants to abstain. The remaining included trials did not mentioned whether sexual intercourse allowed or advised against. Finally, most women were treated with 5‐nitroimidazoles, namely the most commonly prescribed metronidazole (<a href="./references#CD011701-bbs2-0003" title="MengelMB , BergAO , WeaverCH , HermanDJ , HermanSJ , HughesVL , et al. The effectiveness of single‐dose metronidazole therapy for patients and their partners with bacterial vaginosis. Journal of Family Practice1989;28(2):163‐71. ">Mengel 1989</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0005" title="SwedbergJ , SteinerJF , DeissF , SteinerS , DriggersDA . Comparison of single‐dose vs one‐week course of metronidazole for symptomatic bacterial vaginosis. JAMA1985;254(8):1046‐9. ">Swedberg 1985</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>), followed by tinidazole (<a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>). One study used clindamycin cream at bed time (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>). </p> </section> <section id="CD011701-sec-0075"> <h5 class="title">Interventions</h5> <p>All included trials used the oral route to provide the sexual partner's treatment. The most frequently reported intervention was the use of 5‐nitroimidazoles in six studies (<a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a>; <a href="./references#CD011701-bbs2-0003" title="MengelMB , BergAO , WeaverCH , HermanDJ , HermanSJ , HughesVL , et al. The effectiveness of single‐dose metronidazole therapy for patients and their partners with bacterial vaginosis. Journal of Family Practice1989;28(2):163‐71. ">Mengel 1989</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0005" title="SwedbergJ , SteinerJF , DeissF , SteinerS , DriggersDA . Comparison of single‐dose vs one‐week course of metronidazole for symptomatic bacterial vaginosis. JAMA1985;254(8):1046‐9. ">Swedberg 1985</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>). Four of these trials used metronidazole as treatment (<a href="./references#CD011701-bbs2-0003" title="MengelMB , BergAO , WeaverCH , HermanDJ , HermanSJ , HughesVL , et al. The effectiveness of single‐dose metronidazole therapy for patients and their partners with bacterial vaginosis. Journal of Family Practice1989;28(2):163‐71. ">Mengel 1989</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0005" title="SwedbergJ , SteinerJF , DeissF , SteinerS , DriggersDA . Comparison of single‐dose vs one‐week course of metronidazole for symptomatic bacterial vaginosis. JAMA1985;254(8):1046‐9. ">Swedberg 1985</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>), while two trials used tinidazole (<a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>). Only one study used a lincosamide for treatment (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>). </p> <p>The schemes used for metronidazole included 2 g as a single dose (<a href="./references#CD011701-bbs2-0003" title="MengelMB , BergAO , WeaverCH , HermanDJ , HermanSJ , HughesVL , et al. The effectiveness of single‐dose metronidazole therapy for patients and their partners with bacterial vaginosis. Journal of Family Practice1989;28(2):163‐71. ">Mengel 1989</a>; <a href="./references#CD011701-bbs2-0005" title="SwedbergJ , SteinerJF , DeissF , SteinerS , DriggersDA . Comparison of single‐dose vs one‐week course of metronidazole for symptomatic bacterial vaginosis. JAMA1985;254(8):1046‐9. ">Swedberg 1985</a>), 2 g on day one and day three (<a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>), and 500 mg twice daily for seven days (<a href="./references#CD011701-bbs2-0005" title="SwedbergJ , SteinerJF , DeissF , SteinerS , DriggersDA . Comparison of single‐dose vs one‐week course of metronidazole for symptomatic bacterial vaginosis. JAMA1985;254(8):1046‐9. ">Swedberg 1985</a>). The included studies that used tinidazole gave a 2 g single dose (<a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>), or 1 g for four days (<a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a>). One study provided clindamycin 150 mg four times daily for seven consecutive days (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>). None of the included trials assessed the effectiveness of other antibiotic treatments occasionally prescribed in clinical practice, such as aminopenicillins and macrolides. </p> </section> <section id="CD011701-sec-0076"> <h5 class="title">Comparisons</h5> <p>Five trials used placebo (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>; <a href="./references#CD011701-bbs2-0003" title="MengelMB , BergAO , WeaverCH , HermanDJ , HermanSJ , HughesVL , et al. The effectiveness of single‐dose metronidazole therapy for patients and their partners with bacterial vaginosis. Journal of Family Practice1989;28(2):163‐71. ">Mengel 1989</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>). Two trials compared the effectiveness of concurrent antibiotic treatment for the sexual partners with no intervention (<a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a>; <a href="./references#CD011701-bbs2-0005" title="SwedbergJ , SteinerJF , DeissF , SteinerS , DriggersDA . Comparison of single‐dose vs one‐week course of metronidazole for symptomatic bacterial vaginosis. JAMA1985;254(8):1046‐9. ">Swedberg 1985</a>). </p> </section> <section id="CD011701-sec-0077"> <h5 class="title">Outcomes</h5> <p>None of the primary or secondary outcomes were reported by the totality of the retrieved clinical trials and there were some differences in reporting and definition of the outcomes between trials. Four included studies reported recurrence (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>; <a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>), and their presence was established based on the application of Amsel criteria on healthy participants following treatment for BV, with the exception of <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>, which also required the reappearance of symptoms. Only one study assessed this outcome between the first and fourth week (<a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>), and the other three studies assessed for this outcome posterior to the fourth week. </p> <p>Seven studies reported clinical improvement after treatment (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>; <a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a>; <a href="./references#CD011701-bbs2-0003" title="MengelMB , BergAO , WeaverCH , HermanDJ , HermanSJ , HughesVL , et al. The effectiveness of single‐dose metronidazole therapy for patients and their partners with bacterial vaginosis. Journal of Family Practice1989;28(2):163‐71. ">Mengel 1989</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0005" title="SwedbergJ , SteinerJF , DeissF , SteinerS , DriggersDA . Comparison of single‐dose vs one‐week course of metronidazole for symptomatic bacterial vaginosis. JAMA1985;254(8):1046‐9. ">Swedberg 1985</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>), and used the definition of the absence of Amsel's criteria through physical exam plus wet mount. Four trials assessed clinical improvement at the first week (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>), five trials assessed this outcome between the first and fourth week (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>; <a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0005" title="SwedbergJ , SteinerJF , DeissF , SteinerS , DriggersDA . Comparison of single‐dose vs one‐week course of metronidazole for symptomatic bacterial vaginosis. JAMA1985;254(8):1046‐9. ">Swedberg 1985</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>), and four trials assessed it after the fourth week (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>; <a href="./references#CD011701-bbs2-0003" title="MengelMB , BergAO , WeaverCH , HermanDJ , HermanSJ , HughesVL , et al. The effectiveness of single‐dose metronidazole therapy for patients and their partners with bacterial vaginosis. Journal of Family Practice1989;28(2):163‐71. ">Mengel 1989</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>). On the other hand, four studies monitored symptomatic improvement (<a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>). Three trials evaluated symptomatic improvement at the first week (<a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>), two trials assessed it between the first and fourth week (<a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>), and three trials reported it after the fourth week (<a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>). </p> <p>Finally, three trials reported the frequency of minor adverse events during treatment. Two of them captured the information through symptoms reported by participants (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>), and the other trial used a questionnaire (<a href="./references#CD011701-bbs2-0003" title="MengelMB , BergAO , WeaverCH , HermanDJ , HermanSJ , HughesVL , et al. The effectiveness of single‐dose metronidazole therapy for patients and their partners with bacterial vaginosis. Journal of Family Practice1989;28(2):163‐71. ">Mengel 1989</a>). The minor side effects reported in sexual partners of women treated for BV were the presence of nausea, stomachache, metallic taste and dizziness. We did not obtain any data on the secondary outcomes serious adverse events and cost‐effectiveness of the intervention. </p> </section> <section id="CD011701-sec-0078"> <h5 class="title">Length of follow‐up</h5> <p>There were some differences in length of follow‐up between the included studies, which followed participants for either three (<a href="./references#CD011701-bbs2-0005" title="SwedbergJ , SteinerJF , DeissF , SteinerS , DriggersDA . Comparison of single‐dose vs one‐week course of metronidazole for symptomatic bacterial vaginosis. JAMA1985;254(8):1046‐9. ">Swedberg 1985</a>), four (<a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>), five (<a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>), eight (<a href="./references#CD011701-bbs2-0003" title="MengelMB , BergAO , WeaverCH , HermanDJ , HermanSJ , HughesVL , et al. The effectiveness of single‐dose metronidazole therapy for patients and their partners with bacterial vaginosis. Journal of Family Practice1989;28(2):163‐71. ">Mengel 1989</a>) or 12 weeks (<a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>; <a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a>). </p> </section> </section> <section id="CD011701-sec-0079"> <h4 class="title">Excluded studies</h4> <p>We excluded 13 studies for the following reasons: 10 studies were not RCTs or did not provide a comparison group (all sexual partners were treated) and two studies did not provide a valid intervention (the sexual partners did not received antibiotic treatment or not all women were treated) (see the '<a href="./references#CD011701-sec-0131" title="">Characteristics of excluded studies</a>' table). One trial is currently recruiting participants (see the '<a href="./references#CD011701-sec-0132" title="">Characteristics of ongoing studies</a>' table). </p> </section> </section> <section id="CD011701-sec-0080"> <h3 class="title">Risk of bias in included studies</h3> <p>We have summarized the 'Risk of bias' assessment in <a href="#CD011701-fig-0002">Figure 2</a> and <a href="#CD011701-fig-0003">Figure 3</a>. Also, we provided additional details of the included trials in the '<a href="./references#CD011701-sec-0130" title="">Characteristics of included studies</a>' tables. </p> <div class="figure" id="CD011701-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies." data-id="CD011701-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD011701-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study." data-id="CD011701-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study. </p> </div> </div> </div> <section id="CD011701-sec-0081"> <h4 class="title">Allocation</h4> <section id="CD011701-sec-0082"> <h5 class="title">Random sequence generation (checking for possible selection bias)</h5> <p>Four trials adequately reported the random sequence generation method by using a computer‐generated randomisation list, so that selection bias at entry was low (<a href="./references#CD011701-bbs2-0003" title="MengelMB , BergAO , WeaverCH , HermanDJ , HermanSJ , HughesVL , et al. The effectiveness of single‐dose metronidazole therapy for patients and their partners with bacterial vaginosis. Journal of Family Practice1989;28(2):163‐71. ">Mengel 1989</a>; <a href="./references#CD011701-bbs2-0005" title="SwedbergJ , SteinerJF , DeissF , SteinerS , DriggersDA . Comparison of single‐dose vs one‐week course of metronidazole for symptomatic bacterial vaginosis. JAMA1985;254(8):1046‐9. ">Swedberg 1985</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>). The remaining included trials did not report the random sequence generation methods, and the risk of selection bias at entry was unclear (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>; <a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>). </p> </section> <section id="CD011701-sec-0083"> <h5 class="title">Allocation concealment (checking for possible selection bias)</h5> <p>Two trials adequately implemented a valid allocation concealment method using sequentially numbered drugs containers (<a href="./references#CD011701-bbs2-0003" title="MengelMB , BergAO , WeaverCH , HermanDJ , HermanSJ , HughesVL , et al. The effectiveness of single‐dose metronidazole therapy for patients and their partners with bacterial vaginosis. Journal of Family Practice1989;28(2):163‐71. ">Mengel 1989</a>), or by pharmacy‐controlled allocation (<a href="./references#CD011701-bbs2-0005" title="SwedbergJ , SteinerJF , DeissF , SteinerS , DriggersDA . Comparison of single‐dose vs one‐week course of metronidazole for symptomatic bacterial vaginosis. JAMA1985;254(8):1046‐9. ">Swedberg 1985</a>); thus the risk of selection bias at entry in these trials was low. The five remaining included trials did not report the method used to conceal allocation to interventions prior to assignment, and the risk of selection bias at entry was unclear (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>; <a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>). </p> </section> </section> <section id="CD011701-sec-0084"> <h4 class="title">Blinding</h4> <p>Five trials used placebo for the control group to blind trial participants and personnel, and we judged the risk of performance bias as low (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>; <a href="./references#CD011701-bbs2-0003" title="MengelMB , BergAO , WeaverCH , HermanDJ , HermanSJ , HughesVL , et al. The effectiveness of single‐dose metronidazole therapy for patients and their partners with bacterial vaginosis. Journal of Family Practice1989;28(2):163‐71. ">Mengel 1989</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>). The trial authors assessed two outcomes, recurrence and clinical improvement objectively, in contrast with other outcomes, such as symptomatic improvement and side effects pain, which were subjectively evaluated. However, we judged that the blinding of the outcome assessors from knowledge of which intervention each participant received prevented the risk of detection bias. </p> <p>The remaining two trials compared the concurrent use of antibiotic treatment with no intervention (<a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a>; <a href="./references#CD011701-bbs2-0005" title="SwedbergJ , SteinerJF , DeissF , SteinerS , DriggersDA . Comparison of single‐dose vs one‐week course of metronidazole for symptomatic bacterial vaginosis. JAMA1985;254(8):1046‐9. ">Swedberg 1985</a>). <a href="./references#CD011701-bbs2-0005" title="SwedbergJ , SteinerJF , DeissF , SteinerS , DriggersDA . Comparison of single‐dose vs one‐week course of metronidazole for symptomatic bacterial vaginosis. JAMA1985;254(8):1046‐9. ">Swedberg 1985</a> was unblinded to personnel and trial participants and was at high risk of performance bias. However, we appraised the outcome clinical improvement as at low risk of detection bias. This is because it was objectively assessed with Amsel's criteria, and lack of blinding of the outcome assessor was unlikely to affect the results. We considered <a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a> as at high risk of performance and detection bias because was unblinded to personnel and trial participants. Also, the outcomes recurrence and symptomatic improvement were subjectively assessed and lack of blinding of the outcome assessor was likely to affect the results. The trial authors objectively assessed the outcome of clinical cure through Amsel's criteria, which made detection bias unlikely for this outcome. </p> </section> <section id="CD011701-sec-0085"> <h4 class="title">Incomplete outcome data</h4> <p>Three trials appropriately stated the attrition and exclusions at each stage and the reasons were balanced across groups (<a href="./references#CD011701-bbs2-0003" title="MengelMB , BergAO , WeaverCH , HermanDJ , HermanSJ , HughesVL , et al. The effectiveness of single‐dose metronidazole therapy for patients and their partners with bacterial vaginosis. Journal of Family Practice1989;28(2):163‐71. ">Mengel 1989</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>). In addition, the level of missing data was not over 20% and the attrition or exclusion probably was unrelated to the outcomes, which made attrition bias unlikely. </p> <p>We assessed two trials as at unclear risk of bias (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>). In <a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>, we judged the outcomes of clinical cure at 1, 4 and 12 weeks and gastrointestinal symptoms as at low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups). However, we assessed the outcome of recurrence as at high risk of bias because the level of missing data was over 20%. Something similar occurred with <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>, where we judged the outcomes of symptomatic improvement and clinical cure at the first and fourth week as at low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups). However, for the same outcomes at 12 weeks, the risk of bias was high according to the level of missing data (greater than 20%). </p> <p>Two trials had missing data greater that 20% and did not state the reasons why (<a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a>; <a href="./references#CD011701-bbs2-0005" title="SwedbergJ , SteinerJF , DeissF , SteinerS , DriggersDA . Comparison of single‐dose vs one‐week course of metronidazole for symptomatic bacterial vaginosis. JAMA1985;254(8):1046‐9. ">Swedberg 1985</a>); the trial authors conducted the analyses only for those participants who were completely treated (per protocol analysis). We assessed these trials as at high risk of bias. </p> </section> <section id="CD011701-sec-0086"> <h4 class="title">Selective reporting</h4> <p>The trial protocol was unavailable for each of the included trials (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>; <a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a>; <a href="./references#CD011701-bbs2-0003" title="MengelMB , BergAO , WeaverCH , HermanDJ , HermanSJ , HughesVL , et al. The effectiveness of single‐dose metronidazole therapy for patients and their partners with bacterial vaginosis. Journal of Family Practice1989;28(2):163‐71. ">Mengel 1989</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0005" title="SwedbergJ , SteinerJF , DeissF , SteinerS , DriggersDA . Comparison of single‐dose vs one‐week course of metronidazole for symptomatic bacterial vaginosis. JAMA1985;254(8):1046‐9. ">Swedberg 1985</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>). It is unclear whether or not the published reports included all the expected outcomes, including those that were prespecified. The report had insufficient information to permit judgment of “yes” or “no”, and we rated this factor as at unclear risk of bias in each of the included trials. </p> </section> <section id="CD011701-sec-0087"> <h4 class="title">Other potential sources of bias</h4> <p>Pharmaceutical companies funded four trials (<a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0005" title="SwedbergJ , SteinerJF , DeissF , SteinerS , DriggersDA . Comparison of single‐dose vs one‐week course of metronidazole for symptomatic bacterial vaginosis. JAMA1985;254(8):1046‐9. ">Swedberg 1985</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>), and academic institutions sponsored two trials (<a href="./references#CD011701-bbs2-0003" title="MengelMB , BergAO , WeaverCH , HermanDJ , HermanSJ , HughesVL , et al. The effectiveness of single‐dose metronidazole therapy for patients and their partners with bacterial vaginosis. Journal of Family Practice1989;28(2):163‐71. ">Mengel 1989</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>). One trial did not mention the funding sources (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>). We judged one trial, <a href="./references#CD011701-bbs2-0003" title="MengelMB , BergAO , WeaverCH , HermanDJ , HermanSJ , HughesVL , et al. The effectiveness of single‐dose metronidazole therapy for patients and their partners with bacterial vaginosis. Journal of Family Practice1989;28(2):163‐71. ">Mengel 1989</a>, as at high risk of bias because of the nature and direction of their results. The remaining studies appeared to be free from other sources of bias. </p> </section> </section> <section id="CD011701-sec-0088"> <h3 class="title" id="CD011701-sec-0088">Effects of interventions</h3> <p>See: <a href="./full#CD011701-tbl-0001"><b>Summary of findings for the main comparison</b> Any antibiotic treatment versus placebo</a>; <a href="./full#CD011701-tbl-0002"><b>Summary of findings 2</b> Any antibiotic treatment versus no intervention</a>; <a href="./full#CD011701-tbl-0003"><b>Summary of findings 3</b> Any antibiotic treatment versus placebo</a> </p> <section id="CD011701-sec-0089"> <h4 class="title">1. Any antibiotic treatment versus placebo</h4> <p>Five trials ( <a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>; <a href="./references#CD011701-bbs2-0003" title="MengelMB , BergAO , WeaverCH , HermanDJ , HermanSJ , HughesVL , et al. The effectiveness of single‐dose metronidazole therapy for patients and their partners with bacterial vaginosis. Journal of Family Practice1989;28(2):163‐71. ">Mengel 1989</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>) including 854 participants compared any antibiotic treatment versus placebo. They did not all contribute data to each outcome. </p> <section id="CD011701-sec-0090"> <h5 class="title">1.1.Recurrence of BV between the first and fourth week</h5> <p>Only one trial reported on this outcome (<a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>). There was no evidence of significant difference between antibiotic treatment and placebo in the recurrence between first and fourth week of treatment (RR 1.28, 95% CI 0.68 to 2.43; 218 participants, one study; <a href="./references#CD011701-fig-0010" title="">Analysis 1.1</a>). The quality of evidence was low due to the limitations of imprecision. </p> </section> <section id="CD011701-sec-0091"> <h5 class="title">1.2. Recurrence of BV after the fourth week</h5> <p>The results correspond to the meta‐analysis of three trials (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>). There was no evidence of significant difference between antibiotic treatment and placebo in recurrence of BV after the fourth week of treatment (RR 1.00, 95% CI 0.67 to 1.52; 372 participants, three studies; I² statistic = 17%; <a href="./references#CD011701-fig-0011" title="">Analysis 1.2</a>; <a href="#CD011701-fig-0004">Figure 4</a>). The quality of the evidence was very low due to the limitations of imprecision. </p> <div class="figure" id="CD011701-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Any antibiotic treatment versus placebo, outcome: 1.2 Recurrence of BV after the fourth week." data-id="CD011701-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Any antibiotic treatment versus placebo, outcome: 1.2 Recurrence of BV after the fourth week. </p> </div> </div> </div> </section> <section id="CD011701-sec-0092"> <h5 class="title">1.3. Clinical improvement during the first week</h5> <p>The results correspond to the meta‐analysis of four trials (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>). There was no evidence of significant difference in clinical improvement during the first week (RR 0.99, 95% CI 0.96 to 1.03; 712 participants, four studies; I² statistic = 14%; <a href="./references#CD011701-fig-0012" title="">Analysis 1.3</a>; <a href="#CD011701-fig-0005">Figure 5</a>). The quality of the evidence was high. </p> <div class="figure" id="CD011701-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Any antibiotic treatment versus placebo, outcome: 1.3 Clinical improvement during the first week." data-id="CD011701-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Any antibiotic treatment versus placebo, outcome: 1.3 Clinical improvement during the first week. </p> </div> </div> </div> </section> <section id="CD011701-sec-0093"> <h5 class="title">1.4. Clinical improvement between the first and fourth week</h5> <p>The results correspond to the meta‐analysis of three trials (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>). There was no evidence of significant difference in clinical improvement between the first and fourth week (RR 1.02, 95% CI 0.94 to 1.11; 590 participants, three studies; I² statistic = 31%; <a href="./references#CD011701-fig-0013" title="">Analysis 1.4</a>; <a href="#CD011701-fig-0006">Figure 6</a>). The quality of the evidence was high. </p> <div class="figure" id="CD011701-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Any antibiotic treatment versus placebo, outcome: 1.4 Clinical improvement between the first and fourth week." data-id="CD011701-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Any antibiotic treatment versus placebo, outcome: 1.4 Clinical improvement between the first and fourth week. </p> </div> </div> </div> </section> <section id="CD011701-sec-0094"> <h5 class="title">1.5. Clinical improvement after the fourth week</h5> <p>The results correspond to the meta‐analysis of four trials (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>; <a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>; <a href="./references#CD011701-bbs2-0003" title="MengelMB , BergAO , WeaverCH , HermanDJ , HermanSJ , HughesVL , et al. The effectiveness of single‐dose metronidazole therapy for patients and their partners with bacterial vaginosis. Journal of Family Practice1989;28(2):163‐71. ">Mengel 1989</a>). There was no evidence of significant difference in clinical improvement after the fourth week (RR 0.98, 95% CI 0.90 to 1.07; 572 participants, four studies; I² statistic = 0%; <a href="./references#CD011701-fig-0014" title="">Analysis 1.5</a>; <a href="#CD011701-fig-0007">Figure 7</a>). The quality of the evidence was high. </p> <div class="figure" id="CD011701-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Any antibiotic treatment versus placebo, outcome: 1.5 Clinical improvement after the fourth week." data-id="CD011701-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Any antibiotic treatment versus placebo, outcome: 1.5 Clinical improvement after the fourth week. </p> </div> </div> </div> </section> <section id="CD011701-sec-0095"> <h5 class="title">1.6. Symptomatic improvement during the first week</h5> <p>The results correspond to the meta‐analysis of three trials (<a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>). Antibiotic treatment was not associated with a significant symptomatic improvement during the first week (RR 1.06, 95% CI 1.00 to 1.12; 577 participants, three studies; I² statistic = 0%; <a href="./references#CD011701-fig-0015" title="">Analysis 1.6</a>; <a href="#CD011701-fig-0008">Figure 8</a>). The quality of the evidence was high. </p> <div class="figure" id="CD011701-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Any antibiotic treatment versus placebo, outcome: 1.6 Symptomatic improvement during the first week." data-id="CD011701-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG08.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Any antibiotic treatment versus placebo, outcome: 1.6 Symptomatic improvement during the first week. </p> </div> </div> </div> </section> <section id="CD011701-sec-0096"> <h5 class="title">1.7. Symptomatic improvement between the first and fourth week</h5> <p>Two trials informed this outcome (<a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>). There was no evidence of significant difference in this outcome (RR 0.93, 95% CI 0.84 to 1.03; 444 participants, two studies; I² statistic = 0%; <a href="./references#CD011701-fig-0016" title="">Analysis 1.7</a>). The quality of the evidence was high. </p> </section> <section id="CD011701-sec-0097"> <h5 class="title">1.8. Symptomatic improvement after the fourth week</h5> <p>Two trials informed this outcome (<a href="./references#CD011701-bbs2-0004" title="MoiH , ErkkolaR , JerveF , NellemanG , BymoseB , AlaksenK , et al. Should male consorts of women with bacterial vaginosis be treated?. Genitourinary Medicine1989;652(4):263‐8. ">Moi 1989</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>). There was no evidence of significant difference in this outcome (RR 1.03, 95% CI 0.90 to 1.17; 296 participants, two studies; I² statistic = 0%; <a href="./references#CD011701-fig-0017" title="">Analysis 1.8</a>). The quality of the evidence was high. </p> </section> <section id="CD011701-sec-0098"> <h5 class="title">1.9. Minor adverse events during therapy in the sexual partner</h5> <p>The results correspond to the meta‐analysis of three trials (<a href="./references#CD011701-bbs2-0001" title="ColliE , LandoniM , ParazziniF . Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourinary Medicine1997;73(4):267‐70. ">Colli 1997</a>; <a href="./references#CD011701-bbs2-0003" title="MengelMB , BergAO , WeaverCH , HermanDJ , HermanSJ , HughesVL , et al. The effectiveness of single‐dose metronidazole therapy for patients and their partners with bacterial vaginosis. Journal of Family Practice1989;28(2):163‐71. ">Mengel 1989</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>). Antibiotic treatment was associated with a significant minor adverse events report during therapy in sexual partner (RR 2.55, 95% CI 1.55 to 4.18; 477 participants, three studies; I² statistic = 0%; <a href="./references#CD011701-fig-0018" title="">Analysis 1.9</a>; <a href="#CD011701-fig-0009">Figure 9</a>). The quality of the evidence was low due to the limitations of imprecision. </p> <div class="figure" id="CD011701-fig-0009"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 9</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Any antibiotic treatment versus placebo, outcome: 1.9 Minor adverse events during therapy in sexual partner." data-id="CD011701-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG09.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Any antibiotic treatment versus placebo, outcome: 1.9 Minor adverse events during therapy in sexual partner. </p> </div> </div> </div> </section> </section> <section id="CD011701-sec-0099"> <h4 class="title">2. Any antibiotic treatment versus no intervention</h4> <p>Two trials including 172 participants compared the effectiveness of concurrent antibiotic treatment for the sexual partners with no intervention. </p> <section id="CD011701-sec-0100"> <h5 class="title">2.1. Recurrence of BV after the fourth week</h5> <p>One trial informed this outcome (<a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a>). There was no evidence of statistically significance difference in recurrence of BV after the fourth week (RR 1.71, 95% CI 0.65 to 4.55; 51 participants, one study; <a href="./references#CD011701-fig-0019" title="">Analysis 2.1</a>). The quality of the evidence was very low due to the limitations of imprecision, blinding and incomplete outcome data domains. </p> </section> <section id="CD011701-sec-0101"> <h5 class="title">2.2. Clinical improvement between the first and fourth week</h5> <p>Two trials informed this outcome (<a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a>; <a href="./references#CD011701-bbs2-0005" title="SwedbergJ , SteinerJF , DeissF , SteinerS , DriggersDA . Comparison of single‐dose vs one‐week course of metronidazole for symptomatic bacterial vaginosis. JAMA1985;254(8):1046‐9. ">Swedberg 1985</a>) There was no evidence of statistically significance difference in this outcome (RR 0.93, 95% CI 0.70 to 1.25; 152 participants, two studies; I² statistic = 62%; <a href="./references#CD011701-fig-0020" title="">Analysis 2.2</a>). The quality of the evidence was very low due to the limitations of imprecision, substantial heterogeneity, blinding and incomplete outcome data domains. </p> </section> <section id="CD011701-sec-0102"> <h5 class="title">2.3.Symptomatic improvement after the fourth week</h5> <p>One trial informed this outcome (<a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a>). There was no evidence of statistically significance difference in symptomatic improvement after the fourth week (RR 0.66, 95% CI 0.39 to 1.11; 70 participants, one study; <a href="./references#CD011701-fig-0021" title="">Analysis 2.3</a>). The quality of the evidence was very low due to the limitations of imprecision, blinding and incomplete outcome data domains. </p> </section> </section> <section id="CD011701-sec-0103"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We performed subgroup analyses to explore the heterogeneity sources that we found in the analyses of "recurrence" for the comparison antibiotic versus placebo. For this analysis we explored whether differences by antibiotic type (5‐Nitroimidazoles versus Lincosamides) reduced the heterogeneity in the overall effect size. The tests for subgroup effect were not significantly different when we explored heterogeneity source by antibiotic type (assessed after the fourth week, P = 0.16, <a href="./references#CD011701-fig-0022" title="">Analysis 3.1</a>). We did not perform subgroup analysis by antibiotic doses (single versus multiple), because the included trials did not provide enough information for this outcome. </p> <p>In the analyses of “clinical improvement” for the comparison antibiotic versus placebo, neither of the tests for subgroup effect showed evidence of statistically significant differences, analysing by antibiotic type (assessed during first week, P = 0.53, <a href="./references#CD011701-fig-0023" title="">Analysis 3.2</a>; between the first and fourth week, P = 0.53, <a href="./references#CD011701-fig-0024" title="">Analysis 3.3</a>; and after the fourth week, P = 0.92, <a href="./references#CD011701-fig-0025" title="">Analysis 3.4</a>) or by antibiotic doses (assessed during first week, P = 0.18, <a href="./references#CD011701-fig-0027" title="">Analysis 4.1</a>; between the first and fourth week, P = 0.12, <a href="./references#CD011701-fig-0028" title="">Analysis 4.2</a>; and after the fourth week, P = 0.76, <a href="./references#CD011701-fig-0029" title="">Analysis 4.3</a>). The effects of the intervention for these outcomes did not change according to the intervention characteristics. </p> <p>In the analyses of “symptomatic improvement” for the comparison antibiotic versus placebo, neither of the tests for subgroup effect showed evidence of statistically significant differences, analysing by antibiotic doses (assessed during first week, P = 0.29, <a href="./references#CD011701-fig-0030" title="">Analysis 4.4</a>; and between the first and fourth week, P = 0.71, <a href="./references#CD011701-fig-0031" title="">Analysis 4.5</a>). We did not perform subgroup analysis by antibiotic type because the included trials did not provide the required information for these analyses. However, for the analyses "minor adverse events during therapy" for the same comparison, neither of the tests for subgroup effect showed evidence of statistically significant differences, analysing by antibiotic type (P = 0.49, <a href="./references#CD011701-fig-0026" title="">Analysis 3.5</a>) or by dose (P = 0.49, <a href="./references#CD011701-fig-0032" title="">Analysis 4.6</a>). </p> <p>We did not perform the subgroup analysis according to kind of relationship, because not all of the included trials, provided enough information on these basal conditions. Finally we neither analysed by income classifications (low‐ versus high‐income) because all retrieved studies were performed in a high‐income country. </p> </section> <section id="CD011701-sec-0104"> <h4 class="title">Sensitivity analysis</h4> <p>We explored the impact of including trials at high or unclear risk of bias for incomplete outcome data domain in the overall assessment of treatment effects. For the comparison antibiotic treatment versus placebo, neither of the test effects showed evidence of statistically significant differences regardless of the outcome assessed (recurrence, clinical or symptomatic improvement and minor adverse events) or the period of time during which it was measured (during the first, between the first and fourth or after the fourth week). </p> <p>In this sense, we observed the following results for low risk studies.</p> <p> <ul id="CD011701-list-0019"> <li> <p>Recurrence after the fourth week (RR 0.96, 95% CI 0.48 to 1.92; 98 participants, one study; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>) </p> </li> <li> <p>Clinical improvement during first week (RR 0.99, 95% CI 0.93 to 1.05; 242 participants, two studies; I² statistic = 66%; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 199</a>3); between the first and fourth week (RR 1.13, 95% CI 0.95 to 1.35; 233 participants, one study; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 199</a>3); and after the fourth week (RR 1.03, 95% CI 0.90 to 1.17; 243 participants, two studies; I² statistic = 0%; <a href="./references#CD011701-bbs2-0003" title="MengelMB , BergAO , WeaverCH , HermanDJ , HermanSJ , HughesVL , et al. The effectiveness of single‐dose metronidazole therapy for patients and their partners with bacterial vaginosis. Journal of Family Practice1989;28(2):163‐71. ">Mengel 1989</a>; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>) </p> </li> </ul> <ul id="CD011701-list-0020"> <li> <p>Symptomatic improvement during first week (RR 1.06, 95% CI 0.98 to 1.14; 348 participants, two studies; I² statistic = 40%; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>); between the first and fourth week (RR 0.95, 95% CI 0.83 to 1.08; 232 participants, one study; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>); and after the fourth week (RR 1.03, 95% CI 0.83 to 1.29; 107 participants, one study; <a href="./references#CD011701-bbs2-0006" title="VejtorpM , BollerupAC , VejtorpL , FanøeE , NathanE , ReiterA , et al. Bacterial vaginosis: a double‐blind randomized trial of the effect of treatment of the sexual partner. British Journal of Obstetrics and Gynaecology1988;95(9):920‐6. ">Vejtorp 1988</a> ). </p> </li> <li> <p>Minor adverse events of the intervention during therapy (RR 2.76, 95% CI 1.60 to 4.77; 339 participants, two studies; I² statistic = 0%, <a href="./references#CD011701-bbs2-0003" title="MengelMB , BergAO , WeaverCH , HermanDJ , HermanSJ , HughesVL , et al. The effectiveness of single‐dose metronidazole therapy for patients and their partners with bacterial vaginosis. Journal of Family Practice1989;28(2):163‐71. ">Mengel 1989</a>; <a href="./references#CD011701-bbs2-0007" title="VutyavanichT , PongsuthirakP , VannareumolP , RuangsriRA , LuangsookP . A randomized double‐blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstetrics and Gynecology1993;82(4 Pt 1):550‐4. ">Vutyavanich 1993</a>). </p> </li> </ul> </p> <p>We did not perform a sensitivity analysis for the comparison of antibiotic versus no intervention, because we assessed all of the included trials as at high risk of bias for incomplete outcome data domain. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011701-sec-0105" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011701-sec-0105">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011701-sec-0147">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011701-sec-0105"></div> <section id="CD011701-sec-0106"> <h3 class="title" id="CD011701-sec-0106">Summary of main results</h3> <p>Seven RCTs (1026 participants) met our inclusion criteria of this review, and industry funded four of these trials. Five trials (854 patients) compared any antibiotic treatment for the treatment of sexual partners with placebo. Based on high quality evidence antibiotic treatment does not increase the rate of clinical or symptomatic improvement in women during the first week (risk ratio (RR) 0.99, 95% confidence interval (CI) 0.96 to 1.03; 712 participants, four studies; RR 1.06, 95% CI 1.00 to 1.12; 577 patients, three studies, respectively), between the first and fourth week (RR 1.02, 95% CI 0.94 to 1.11; 590 participants, three studies; RR 0.93, 95% CI 0.84 to 1.03; 444 participants, two studies; respectively) or after the fourth week (RR 0.98, 95% CI 0.90 to 1.07; 572 participants, four studies; RR 1.03, 95% CI 0.90 to 1.17; 296 participants, two studies; respectively). Antibiotic treatment does not led to a lower recurrence rate during the first and fourth week (RR 1.28, 95% CI 0.68 to 2.43; 218 participants, one study; low quality evidence) or after the fourth week of treatment (RR 1.00, 95% CI 0.67 to 1.52; 372 participants, three studies; low quality evidence) in women, but increases the frequency of adverse events (most frequently gastrointestinal symptoms) reported by sexual partners (RR 2.55, 95% CI 1.55 to 4.18; 477 participants, three studies; low‐certainty evidence) see the 'Summary of findings' tables <a href="./full#CD011701-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD011701-tbl-0002">summary of findings Table 2</a>; <a href="./full#CD011701-tbl-0003">summary of findings Table 3</a>.<br/> <br/> Two trials (172 participants) compared any antibiotic treatment for the sexual partners with no intervention. When we compared it with no intervention, the effects of antibiotic treatment on recurrence rate after the fourth week (RR 1.71, 95% CI 0.65 to 4.55; 51 participants, one study), clinical improvement between the first and fourth week (RR 0.93, 95% CI 0.70 to 1.25; 152 participants, two studies) and symptomatic improvement after the fourth week (RR 0.66, 95% CI 0.39 to 1.11; 70 participants, one study) were imprecise and there were no differences between groups. We downgraded the quality of the evidence to low or very low. </p> </section> <section id="CD011701-sec-0107"> <h3 class="title" id="CD011701-sec-0107">Overall completeness and applicability of evidence</h3> <p>We conducted a comprehensive search to retrieve all published and unpublished RCTs. We were able to evaluate all primary outcomes except for serious adverse events and the secondary outcome of cost effectiveness of the intervention that were not reported in any trial. The applicability of the evidence into the target population (the sexual partners of women treated for non‐recurrent bacterial vaginosis (BV)) is broad because the retrieved trials were conducted in different clinical settings. In this sense, the result of this systematic review can be applied into clinical practice regardless of the marital status, the form of relationship (monogamous or not), the concurrent use of contraceptive methods or the frequency of sexual intercourse during the treatment. On the other hand, the interventions analysed in the review encompass multiple clinical scenarios that are common in current practice: various antibiotic regimens including 5‐nitroimidazoles and lincosamides with different schemes single dose, and treatments from two to seven days. </p> <p>Finally, because the included studies only assessed the safety and effectiveness of the intervention for heterosexual relationships, the results should not be extrapolated to a different population. </p> </section> <section id="CD011701-sec-0108"> <h3 class="title" id="CD011701-sec-0108">Quality of the evidence</h3> <p>We considered five of the seven included trials to be at low risk of bias. These studies corresponded to the comparison of any antibiotic treatment versus placebo, and consequently with high confidence on the effect estimate for most outcomes. However, for the comparison any antibiotic treatment versus non‐intervention, the confidence on the effect estimate was very low due to trial limitations (lack of blinding and incomplete outcome data), inconsistency (unexplained variability in some results) and some imprecise results (few participants and outcome events with wide CIs). We could not evaluate publication bias, because there were too few included trials into each comparison (see the 'Summary of findings' tables: <a href="./full#CD011701-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD011701-tbl-0002">summary of findings Table 2</a>; <a href="./full#CD011701-tbl-0003">summary of findings Table 3</a>). </p> </section> <section id="CD011701-sec-0109"> <h3 class="title" id="CD011701-sec-0109">Potential biases in the review process</h3> <p>This systematic review has many strengths regarding the review process: we adhered to the predefined objectives and study eligibility criteria; our literature search included an appropriate range of databases and sources, including relevant additional methods to identify relevant reports and retrieve as many eligible studies as possible; and we assessed all studies adequately for risk of bias. Two authors performed data extraction independently. However, we have some concerns about publication bias. Publication bias is a possibility because the included trials were mostly funded by industry and due to the limited number of trials for each comparison. </p> </section> <section id="CD011701-sec-0110"> <h3 class="title" id="CD011701-sec-0110">Agreements and disagreements with other studies or reviews</h3> <p>There are two previous systematic reviews published on this topic (<a href="./references#CD011701-bbs2-0017" title="MehtaSD . Systematic review of randomised trials of treatment of male sexual partners for improved bacteria vaginosis outcomes in women. Sexually Transmitted Diseases2012;39(10):822‐30. ">Mehta 2012</a>; <a href="./references#CD011701-bbs2-0018" title="PotterJ . Should sexual partners of women with bacterial vaginosis receive treatment?. British Journal of General Practice1999;49(448):913‐8. ">Potter 1999</a>). Our review includes one study that the previous two reviews did not include (<a href="./references#CD011701-bbs2-0002" title="HeikkinenJ , VuopalaS . Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecologic and Obstetric Investigation1989;28(2):98‐100. ">Heikkinen 1989</a>). The authors of those reviews considered that a meta‐analysis could not be conducted due to significant risk of bias in the retrieved studies and by some limitations about heterogeneity; however, these were not a limiting issue for a meta‐analysis. Also, as we have shown, the included studies (particularly for the antibiotic treatment versus placebo comparison) are of high quality, there is no significant heterogeneity and we have presented the meta‐analyses. </p> <p>Our conclusions, about the lack of benefit following sexual partner treatment, agree with the recommendation of some important guidelines where this is not recommended (<a href="./references#CD011701-bbs2-0064" title="WorkowskiKA , BolanGA , Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep2015;64(RR‐03):1‐137. ">Workowski 2015</a>; <a href="./references#CD011701-bbs2-0063" title="vanSchalkwykJ , YudinMH , Infectious Disease Committee. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis. Journal of Obstetrics and Gynaecological Canada2015;37(3):266‐76. ">van Schalkwyk 2015</a>). However, these recommendations were not based on a systematic and explicit approach. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011701-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD011701-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/full#CD011701-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies." data-id="CD011701-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/full#CD011701-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study." data-id="CD011701-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/full#CD011701-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Any antibiotic treatment versus placebo, outcome: 1.2 Recurrence of BV after the fourth week." data-id="CD011701-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Any antibiotic treatment versus placebo, outcome: 1.2 Recurrence of BV after the fourth week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/full#CD011701-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Any antibiotic treatment versus placebo, outcome: 1.3 Clinical improvement during the first week." data-id="CD011701-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Any antibiotic treatment versus placebo, outcome: 1.3 Clinical improvement during the first week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/full#CD011701-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Any antibiotic treatment versus placebo, outcome: 1.4 Clinical improvement between the first and fourth week." data-id="CD011701-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Any antibiotic treatment versus placebo, outcome: 1.4 Clinical improvement between the first and fourth week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/full#CD011701-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Any antibiotic treatment versus placebo, outcome: 1.5 Clinical improvement after the fourth week." data-id="CD011701-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Any antibiotic treatment versus placebo, outcome: 1.5 Clinical improvement after the fourth week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/full#CD011701-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-AFig-FIG08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-AFig-FIG08.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Any antibiotic treatment versus placebo, outcome: 1.6 Symptomatic improvement during the first week." data-id="CD011701-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Any antibiotic treatment versus placebo, outcome: 1.6 Symptomatic improvement during the first week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/full#CD011701-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-AFig-FIG09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-AFig-FIG09.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Any antibiotic treatment versus placebo, outcome: 1.9 Minor adverse events during therapy in sexual partner." data-id="CD011701-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 9</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Any antibiotic treatment versus placebo, outcome: 1.9 Minor adverse events during therapy in sexual partner. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/full#CD011701-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-AFig-FIG09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any antibiotic treatment versus placebo, Outcome 1 Recurrence of BV between the first and fourth week." data-id="CD011701-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Any antibiotic treatment versus placebo, Outcome 1 Recurrence of BV between the first and fourth week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any antibiotic treatment versus placebo, Outcome 2 Recurrence of BV after the fourth week." data-id="CD011701-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Any antibiotic treatment versus placebo, Outcome 2 Recurrence of BV after the fourth week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any antibiotic treatment versus placebo, Outcome 3 Clinical improvement during the first week." data-id="CD011701-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Any antibiotic treatment versus placebo, Outcome 3 Clinical improvement during the first week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-001-04.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any antibiotic treatment versus placebo, Outcome 4 Clinical improvement between the first and fourth week." data-id="CD011701-fig-0013" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Any antibiotic treatment versus placebo, Outcome 4 Clinical improvement between the first and fourth week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-001-05.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any antibiotic treatment versus placebo, Outcome 5 Clinical improvement after the fourth week." data-id="CD011701-fig-0014" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Any antibiotic treatment versus placebo, Outcome 5 Clinical improvement after the fourth week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-001-06.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any antibiotic treatment versus placebo, Outcome 6 Symptomatic improvement during the first week." data-id="CD011701-fig-0015" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Any antibiotic treatment versus placebo, Outcome 6 Symptomatic improvement during the first week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any antibiotic treatment versus placebo, Outcome 7 Symptomatic improvement between the first and fourth week." data-id="CD011701-fig-0016" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Any antibiotic treatment versus placebo, Outcome 7 Symptomatic improvement between the first and fourth week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any antibiotic treatment versus placebo, Outcome 8 Symptomatic improvement after the fourth week." data-id="CD011701-fig-0017" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Any antibiotic treatment versus placebo, Outcome 8 Symptomatic improvement after the fourth week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-001-09.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any antibiotic treatment versus placebo, Outcome 9 Minor adverse events during therapy in sexual partner." data-id="CD011701-fig-0018" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Any antibiotic treatment versus placebo, Outcome 9 Minor adverse events during therapy in sexual partner. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any antibiotic treatment versus no intervention, Outcome 1 Recurrence of BV after the fourth week." data-id="CD011701-fig-0019" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Any antibiotic treatment versus no intervention, Outcome 1 Recurrence of BV after the fourth week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any antibiotic treatment versus no intervention, Outcome 2 Clinical improvement between the first and fourth week." data-id="CD011701-fig-0020" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Any antibiotic treatment versus no intervention, Outcome 2 Clinical improvement between the first and fourth week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any antibiotic treatment versus no intervention, Outcome 3 Symptomatic improvement after the fourth week." data-id="CD011701-fig-0021" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Any antibiotic treatment versus no intervention, Outcome 3 Symptomatic improvement after the fourth week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Any antibiotic treatment versus placebo (by antibiotic type), Outcome 1 Recurrence of BV after the fourth week." data-id="CD011701-fig-0022" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Any antibiotic treatment versus placebo (by antibiotic type), Outcome 1 Recurrence of BV after the fourth week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Any antibiotic treatment versus placebo (by antibiotic type), Outcome 2 Clinical improvement during the first week." data-id="CD011701-fig-0023" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Any antibiotic treatment versus placebo (by antibiotic type), Outcome 2 Clinical improvement during the first week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Any antibiotic treatment versus placebo (by antibiotic type), Outcome 3 Clinical improvement between the first and fourth week." data-id="CD011701-fig-0024" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Any antibiotic treatment versus placebo (by antibiotic type), Outcome 3 Clinical improvement between the first and fourth week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Any antibiotic treatment versus placebo (by antibiotic type), Outcome 4 Clinical improvement after the fourth week." data-id="CD011701-fig-0025" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Any antibiotic treatment versus placebo (by antibiotic type), Outcome 4 Clinical improvement after the fourth week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Any antibiotic treatment versus placebo (by antibiotic type), Outcome 5 Minor adverse events during therapy in sexual partner." data-id="CD011701-fig-0026" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Any antibiotic treatment versus placebo (by antibiotic type), Outcome 5 Minor adverse events during therapy in sexual partner. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Any antibiotic treatment versus placebo (by dose), Outcome 1 Clinical improvement during the first week." data-id="CD011701-fig-0027" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Any antibiotic treatment versus placebo (by dose), Outcome 1 Clinical improvement during the first week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Any antibiotic treatment versus placebo (by dose), Outcome 2 Clinical improvement between the first and fourth week." data-id="CD011701-fig-0028" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Any antibiotic treatment versus placebo (by dose), Outcome 2 Clinical improvement between the first and fourth week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Any antibiotic treatment versus placebo (by dose), Outcome 3 Clinical improvement after the fourth week." data-id="CD011701-fig-0029" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Any antibiotic treatment versus placebo (by dose), Outcome 3 Clinical improvement after the fourth week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Any antibiotic treatment versus placebo (by dose), Outcome 4 Symptomatic improvement during the first week." data-id="CD011701-fig-0030" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Any antibiotic treatment versus placebo (by dose), Outcome 4 Symptomatic improvement during the first week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Any antibiotic treatment versus placebo (by dose), Outcome 5 Symptomatic improvement between the first and fourth week." data-id="CD011701-fig-0031" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Any antibiotic treatment versus placebo (by dose), Outcome 5 Symptomatic improvement between the first and fourth week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Any antibiotic treatment versus placebo (by dose), Outcome 6 Minor adverse events during therapy in sexual partner." data-id="CD011701-fig-0032" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 Any antibiotic treatment versus placebo (by dose), Outcome 6 Minor adverse events during therapy in sexual partner. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Any antibiotic treatment versus placebo (attrition bias), Outcome 1 Recurrence of BV after the fourth week." data-id="CD011701-fig-0033" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Any antibiotic treatment versus placebo (attrition bias), Outcome 1 Recurrence of BV after the fourth week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Any antibiotic treatment versus placebo (attrition bias), Outcome 2 Clinical improvement during the first week." data-id="CD011701-fig-0034" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Any antibiotic treatment versus placebo (attrition bias), Outcome 2 Clinical improvement during the first week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Any antibiotic treatment versus placebo (attrition bias), Outcome 3 Clinical improvement between the first and fourth week." data-id="CD011701-fig-0035" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Any antibiotic treatment versus placebo (attrition bias), Outcome 3 Clinical improvement between the first and fourth week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Any antibiotic treatment versus placebo (attrition bias), Outcome 4 Clinical improvement after the fourth week." data-id="CD011701-fig-0036" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Any antibiotic treatment versus placebo (attrition bias), Outcome 4 Clinical improvement after the fourth week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Any antibiotic treatment versus placebo (attrition bias), Outcome 5 Symptomatic improvement during the first week." data-id="CD011701-fig-0037" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Any antibiotic treatment versus placebo (attrition bias), Outcome 5 Symptomatic improvement during the first week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Any antibiotic treatment versus placebo (attrition bias), Outcome 6 Symptomatic improvement between the first and fourth week." data-id="CD011701-fig-0038" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 Any antibiotic treatment versus placebo (attrition bias), Outcome 6 Symptomatic improvement between the first and fourth week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Any antibiotic treatment versus placebo (attrition bias), Outcome 7 Symptomatic improvement after the fourth week." data-id="CD011701-fig-0039" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 Any antibiotic treatment versus placebo (attrition bias), Outcome 7 Symptomatic improvement after the fourth week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011701-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/urn:x-wiley:14651858:media:CD011701:CD011701-CMP-005-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_t/tCD011701-CMP-005-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Any antibiotic treatment versus placebo (attrition bias), Outcome 8 Minor adverse events during therapy in sexual partner." data-id="CD011701-fig-0040" src="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-005-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5 Any antibiotic treatment versus placebo (attrition bias), Outcome 8 Minor adverse events during therapy in sexual partner. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/media/CDSR/CD011701/image_n/nCD011701-CMP-005-08.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011701-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Any antibiotic treatment versus placebo</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Any antibiotic treatment versus placebo for the sexual partners of woman with bacterial vaginosis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> sexual partners of women with bacterial vaginosis<br/> <b>Setting:</b> outpatient clinic<br/> <b>Intervention:</b> any antibiotic treatment<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with any antibiotic treatment</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Recurrence</b> </p> <p>follow‐up 4 to 12 weeks</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.00<br/> (0.67 to 1.52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>372<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> very low<sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>196 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>196 per 1000<br/> (131 to 297) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Clinical improvement</b> </p> <p>follow‐up 1 to 4 weeks</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.02<br/> (0.94 to 1.11) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>590<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>778 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>794 per 1000<br/> (731 to 864) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Clinical improvement</b> </p> <p>follow‐up 4 to 12 weeks</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.98<br/> (0.90 to 1.07) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>572<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>778 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>762 per 1000<br/> (700 to 832) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Symptomatic improvement</b> </p> <p>during the first week</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.06<br/> (1.00 to 1.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>577<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>863 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>914 per 1000<br/> (863 to 966) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Symptomatic improvement</b> </p> <p>follow‐up 1 to 4 weeks</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.93<br/> (0.84 to 1.03) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>444<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>801 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>745 per 1000<br/> (673 to 825) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Symptomatic improvement</b> </p> <p>follow‐up 4 to 12 weeks</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.03<br/> (0.90 to 1.17) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>296<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>743 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>766 per 1000<br/> (669 to 870) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Minor adverse events in sexual partner</b> <br/> follow‐up: 1 to 12 weeks </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.55<br/> (1.55 to 4.18) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>477<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>80 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>204 per 1000<br/> (124 to 335) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>Abbreviations: CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>OR:</b> odds ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by 1 level for significant imprecision as the 95% CI was below 0.75 and over 1.25.<br/> <sup>2</sup>Downgraded by 2 levels for imprecision as the 95% CI crosses through 0.75 and 1.25 and OIS is not achieved.<br/> <sup>3</sup>Downgraded by 2 levels for imprecision because the Optimal information size (OIS) was not achieved. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Any antibiotic treatment versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/full#CD011701-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011701-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Any antibiotic treatment versus no intervention</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Any antibiotic treatment versus no intervention</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> sexual partners of women with bacterial vaginosis<br/> <b>Setting:</b> outpatient clinic<br/> <b>Intervention:</b> any antibiotic treatment<br/> <b>Comparison:</b> no intervention </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no intervention</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with any antibiotic treatment</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Recurrence</b> </p> <p>follow‐up 4 to 12 weeks</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.71<br/> (0.65 to 4.55) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>51<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> very low<sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>194 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>333 per 1000<br/> (126 to 885) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Clinical improvement</b> </p> <p>follow‐up 1 to 4 weeks</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.93<br/> (0.70 to 1.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>152<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> very low<sup>1,2,3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>851 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>792 per 1000<br/> (596 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Symptomatic improvement</b> </p> <p>follow‐up 4 to 12 weeks</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.66<br/> (0.39 to 1.11) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>70<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> very low<sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>630 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>416 per 1000<br/> (246 to 700) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>Abbreviations: CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>OR:</b> odds ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by 2 levels due to imprecision as OIS was not achieved and the 95% CI crosses through 0.75 and 1.25.<br/> <sup>2</sup>Downgraded by 2 levels as there were some limitations on blinding and incomplete outcome data domains.<br/> <sup>3</sup>Downgraded by 1 level for substantial heterogeneity (I² statistic is greater than 40%). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Any antibiotic treatment versus no intervention</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/full#CD011701-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011701-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Any antibiotic treatment versus placebo</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Any antibiotic treatment versus placebo</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> sexual partners of women with bacterial vaginosis<br/> <b>Setting:</b> outpatient clinics<br/> <b>Intervention:</b> any antibiotic treatment<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with any antibiotic treatment</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Recurrence</b> <br/> follow‐up 1 to 4 weeks </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.28<br/> (0.68 to 2.43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>218<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>132 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>169 per 1000<br/> (90 to 321) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Clinical improvement</b> during the first week </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.99<br/> (0.96 to 1.03) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>712<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> high </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>951 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>942 per 1000<br/> (913 to 980) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>Abbreviations: CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>OR:</b> odds ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by 2 levels for imprecision as the 95% CI crosses through 0.75 and 1.25 and OIS is not achieved. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Any antibiotic treatment versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/full#CD011701-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011701-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Any antibiotic treatment versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Recurrence of BV between the first and fourth week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.68, 2.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Recurrence of BV after the fourth week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>372</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.67, 1.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Clinical improvement during the first week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>712</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.96, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Clinical improvement between the first and fourth week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>590</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.94, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Clinical improvement after the fourth week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>572</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.90, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Symptomatic improvement during the first week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>577</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [1.00, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Symptomatic improvement between the first and fourth week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>444</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.84, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Symptomatic improvement after the fourth week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>296</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.90, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Minor adverse events during therapy in sexual partner <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>477</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.55 [1.55, 4.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Any antibiotic treatment versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011701-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Any antibiotic treatment versus no intervention</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Recurrence of BV after the fourth week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.71 [0.65, 4.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Clinical improvement between the first and fourth week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.70, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Symptomatic improvement after the fourth week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.39, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Any antibiotic treatment versus no intervention</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011701-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Any antibiotic treatment versus placebo (by antibiotic type)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Recurrence of BV after the fourth week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>372</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.67, 1.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 5‐Nitroimidazoles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.74, 1.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Lincosamides</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.19, 1.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Clinical improvement during the first week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>712</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.96, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 5‐Nitroimidazoles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>574</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.95, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Lincosamides</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>138</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.94, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Clinical improvement between the first and fourth week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>590</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.94, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 5‐Nitroimidazoles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>451</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.93, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Lincosamides</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.87, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Clinical improvement after the fourth week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>572</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.90, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 5‐Nitroimidazoles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>433</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.90, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Lincosamides</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.78, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Minor adverse events during therapy in sexual partner <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>477</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.55 [1.55, 4.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 5‐Nitroimidazoles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>339</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.76 [1.60, 4.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Lincosamides</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>138</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.75 [0.54, 5.71]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Any antibiotic treatment versus placebo (by antibiotic type)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011701-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Any antibiotic treatment versus placebo (by dose)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical improvement during the first week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>712</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.96, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Single</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>241</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.89, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Multiple dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>471</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.97, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Clinical improvement between the first and fourth week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>590</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.94, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Single</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>233</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.95, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Multiple dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>357</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.89, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Clinical improvement after the fourth week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>572</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.90, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Single</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>138</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.86, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Multiple dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>434</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.88, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Symptomatic improvement during the first week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>577</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [1.00, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Single</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>241</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.94, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Multiple dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>336</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [1.01, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Symptomatic improvement between the first and fourth week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>444</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.84, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Single</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.83, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Multiple dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.78, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Minor adverse events during therapy in sexual partner <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>477</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.55 [1.55, 4.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Single</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>339</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.76 [1.60, 4.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Multiple dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>138</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.75 [0.54, 5.71]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Any antibiotic treatment versus placebo (by dose)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011701-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Any antibiotic treatment versus placebo (attrition bias)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Recurrence of BV after the fourth week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>372</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.67, 1.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.48, 1.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>274</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.62, 1.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Clinical improvement during the first week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>712</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.96, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>342</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.93, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>370</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.96, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Clinical improvement between the first and fourth week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>590</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.94, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>233</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.95, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>357</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.89, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Clinical improvement after the fourth week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>572</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.90, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>243</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.90, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>329</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.84, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Symptomatic improvement during the first week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>577</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [1.00, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>348</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.98, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>229</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.97, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Symptomatic improvement between the first and fourth week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>444</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.84, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.83, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.78, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Symptomatic improvement after the fourth week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>296</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.90, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.83, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>189</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.87, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Minor adverse events during therapy in sexual partner <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>477</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.55 [1.55, 4.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Low risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>339</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.76 [1.60, 4.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Unclear risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>138</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.75 [0.54, 5.71]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Any antibiotic treatment versus placebo (attrition bias)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011701.pub2/references#CD011701-tbl-0008">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011701.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD011701-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011701-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD011701-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD011701-note-0002">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ru#CD011701-note-0001">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011701-note-0012">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011701\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011701\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011701\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011701\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011701\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011701\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011701\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011701\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011701\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011701\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011701\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011701\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011701\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011701\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011701\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011701\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011701\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011701\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=gpg7sF9V&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011701.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011701.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011701.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011701.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011701.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740719510165"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011701.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740719510169"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011701.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dea8459f39373',t:'MTc0MDcxOTUxMC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 